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Abstract 
 
 Genetically engineered bacteria, especially Escherichia coli, find applications in both 
university and industry-based research; one important purpose being heterologous 
production of proteins. Experiences from empiric genetic engineering strategies in pursuit of 
maximizing or, generally speaking, modulating protein production levels have demonstrated 
that results are often unpredictable. Even after several decades of research in this field, the 
complex interplay of the many different genetic and physiological parameters that affect 
protein production levels are still not fully understood. Among the various expression 
vectors, mini-RK2 replicons containing the positively regulated xylS/Pm system can be 
used in E. coli and other Gram-negative bacteria. Using recombinant E. coli strains 
harboring these vectors as a basis, the influence of different genetic and physiological 
parameters on recombinant gene expression was systematically compared during this PhD 
project.  
 The first parameter studied was how different regulated promoter systems influence 
expression. Interestingly, a survey of the scientific literature indicated that the performance 
of commonly used expression systems such as LacI/PT7lac, LacI/Ptrc, and AraC/PBAD, (and 
also XylS/Pm) had to a very limited extent been properly and systematically compared to 
each other. Such a comparison was selected as one objective of this PhD project. Given a 
common vector backbone and expression system insertion points, this comparison made it 
possible to understand the influence of the systems on production of different selected 
proteins. This study confirmed that no system was superior to meet all requirements an 
ideal system should have. However, it was possible to recommend certain systems for 
different expression purposes. The LacI/PT7lac system, for example, was still best suited for 
achieving most total production judged by the vast amount of accumulated transcript and 
total recombinant protein. As for production of soluble (and active) protein, however, use of 
a variant of XylS/Pm (XylS/Pm ML1-17) or AraC/PBAD were more beneficial for some 
proteins. The plasmid vector tools developed for this study may be used in future studies to 
analyze limiting factors for production of in principle any specific protein, including 
production in an active form. 
 The second genetic parameter included in the systematic studies was the DNA 
region corresponding to the 5ƍ-UTR of mRNA. My findings demonstrate that 5ƍ-UTR DNA 
sequences with strong RBS (like the PT7lac UTR), could enhance protein (here: ȕ-lactamase) 
production from XylS/Pm (7-fold) compared to the Pm 5ƍ-UTR. Still, Pm 5ƍ-UTR DNA 
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sequences that were obtained by combinatorial mutagenesis and screening approaches 
gave rise to even higher protein amounts (up to 20-fold). Also, the relative changes could 
not be predicted using current sequence analysis tools. Prior to this study, it was already 
shown that a 5ƍ-UTR DNA region plays a key role in expression due to its involvement in 
transcription, translation and transcript stability. Therefore, it was hypothesized that one 
cannot study the effect of 5ƍ-UTR DNA regions on protein production based on parameters 
influencing translation only (e.g. length of a Shine-Dalgarno sequence). To determine 
sequence features that influence transcription and to distinguish them from features 
influencing translation, combinatorial mutagenesis and screening using two efficient vector 
tools was applied. The new 5ƍ-UTR DNA regions identified with these tools led to primarily 
stimulated transcript accumulation or protein production indeed, but it was not possible to 
identify positional hot-spots for mutations that specifically influenced either process. It was 
however possible to combine a 5ƍ-UTR DNA region carrying mutations that primarily 
stimulated transcript accumulation with a 5ƍ-UTR DNA region whose mutations primarily 
stimulated translation The total improvement achieved by this strategy was an impressive 
170- fold compared to the native 5ƍ-UTR. It can also be possible to adjust this 5ƍ-UTR DNA 
region to other promoters and to other coding regions in the future. Hopefully, this strategy 
will enable more rational design in recombinant protein expression.   
 Among the remaining parameters that were varied, it was not surprisingly growth 
temperature, inducer concentration and plasmid (and indirectly gene) copy number that 
influenced recombinant protein production. This latter parameter also influenced culture 
heterogeneity at the single-cell level. 
 The last parameter that this work focused on was the qualitative influence of the 
expression host on the final product. Certain proteins are prone to be problematic for 
functional expression in E. coli even independent of the expression levels, the growth 
conditions or the protein engineering strategies. This was demonstrated by the example of 
the two difficult-to-express Norwegian Salmonid alphavirus E1 and E2 capsid proteins. 
Therefore, exploring the use of alternative bacterial hosts was considered; Pseudomonas 
putida, the organism XylS/Pm originates from, as well as cold-adapted members of the 
genus Pseudomonas. Vectors developed in this project were suitable to be directly 
transferred to these hosts; and at least for one protein (mCherry), even higher protein 
production levels could be achieved in P. putida compared to E. coli. The cold-adapted 
Pseudomonas strains also showed potential to be used as expression hosts for certain 
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proteins, however, slow growth and low expression levels demonstrated the need to 
engineer these novel hosts further in the future. 
 The findings presented in this work not only expand our current understanding of 
gene expression in general, but also help to approach the goal to optimize bacterial 
recombinant protein production in a more rational manner than is currently possible.  
 
 vi
 vii
List of papers 
 
Paper I  a BALZER, S., KUCHAROVA, V., MEGERLE, J., LALE, R., BRAUTASET, T. and 
VALLA, S. (2013) A comparative analysis of the properties of regulated promoter 
systems commonly used for recombinant gene expression in Escherichia coli. 
Microb Cell Fact, 12, 26. 
 
Paper II b BALZER, S., LORENTZEN, J.A. VALLA, S. and LALE, R. Improving bacterial 
recombinant gene expression by separate optimization and combination of 
two functional parts of 5ƍ-UTR sequences. (draft manuscript) 
 
Paper III  c TØNDERVIK, A.*, BALZER, S.*, HAUGEN, T., SLETTA, H., RODE, M., 
LINDMO, K., ELLINGSEN, T. E. and BRAUTASET, T. (2013) High production of 
recombinant Norwegian salmonid alphavirus E1 and E2 proteins in Escherichia 
coli by fusion to secretion signal sequences and removal of hydrophobic 
domains. Biotechnology and Bioprocess Engineering, 18, 742-750. 
* joint first authors 
 
Contributions 
a As the first author, I contributed to this article by participating in the design of the story, 
planning of the experiments and methodology design, by carrying out most of the 
experiments (except for work on scFv173-2-5-AP and IL-1RA, VK), by participating in data 
analysis and in the interpretation of the results, by writing the first draft of the manuscript 
and by editing the final version. 
 
b As the first author, I contributed to this article by participating in the design of the story, 
planning of the experiments, by carrying out most of the experiments (except for 
construction and validation of the artificial operon constructs (RL) and work on Figure 2 
which was shared between JAL and myself), by participating in data analysis and in the 
interpretation of the results, by writing the first draft of the manuscript and by editing the 
final version. 
 
c As joint first author, I designed the genetic constructs, planned and performed the 
experiments in shake-flasks including protein purification, participated in the interpretation 
of the results, wrote the first draft of the manuscript and participated in editing the final 
version.  
 viii
 
 ix
Abbreviations 
 
API  active pharmaceutical ingredient 
CHO  Chinese hamster ovary 
CoFi blot colony filtration blot 
CRP  cAMP receptor protein 
CSP  consensus signal peptide 
CTD  C-terminal domain 
EC  elongation complex 
EF  elongation factor 
EMEA  European Medicines Agency 
FDA  Food and Drug Administration 
FP  fusion partner 
GFP  green fluorescent protein 
GOI  gene of interest 
GST  glutathione S-transferase 
HCDC  high-cell-density cultivation 
HTS  high-throughput screening 
IB  inclusion body 
IC  initiation complex 
IF  initiation factor 
Inc group plasmid incompatibility group 
IPTG  isopropyl ȕ-D-1-thiogalactopyranoside 
ITS  initially transcribed sequence 
MBP  maltose-binding protein 
MCS  multiple cloning site 
MRS  multimer resolution system 
NSAV  Norwegian Salmonid alphavirus 
NTD  N-terminal domain 
Nus  N-utilization substance 
oriT  origin of transfer 
oriV  origin of vegetative DNA replication 
PIC  preinitiation complex 
PTM  posttranslational modification 
qPCR  relative quantification real-time reverse transcription PCR 
RBS  ribosome binding site (contains the SD sequence and the start codon) 
Rep protein replication initiation protein   
RF  release factor 
RNAP  RNA polymerase  
Rop protein repressor of primer protein 
SD  Shine-Dalgarno sequence (part of an RBS) 
SEVA  Standard European Vector Architecture 
SLIC   sequence- and ligase- independent cloning  
SUMO  small ubiquitin-like modifier 
TF  transcription factor 
TIR  translation initiation rate 
TM  transmembrane domain 
TrfA  trans-acting replication function 
tRNA  transfer RNA 
UP  upstream promoter 
 x
UTR  untranslated region 
xylS/Pm xylS gene and Pm promoter region; specifically used to denote DNA  
  region as part of an expression vector 
XylS/Pm XylS protein and Pm promoter region; general term for the expression  
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 1
1 Introduction  
 
 Bacterial recombinant gene expression is a very general term and implies the use 
cloning and transformation techniques to insert foreign DNA into a heterologous bacterial 
host which is thereby enabled to produce the corresponding recombinant product (mostly 
protein). Since the birth of recombinant DNA technology in the 1970th [1] this field has 
spread into many different research areas studying gene expression in species across the 
whole kingdom. Genetic engineering with the aim to modify a cell's biosynthetic machinery 
is a well-established practice. Motivating factors for further improvements of existing and 
development of novel expression platforms come from both academic research and 
different industries covering the biopharmaceutical, industrial biotechnology, agricultural, 
environmental, chemical and bioenergy sectors, with typical products ranging from 
monoclonal antibodies [2], laundry detergents [3], improved cellulose-degrading 
microorganisms [4] and biosensors [5] to antioxidant pigments [6] and food supplements 
such as amino acids [7]. In the following chapter, some of the most important applications 
of recombinant gene expression will be presented and special attention will be paid to 
classic use in overexpression of single genes as well as applications in other modern 
research disciplines. Afterwards, an overview over the current biological and 
computational tools used to engineer bacterial host strains will be given. In the second 
chapter, the focus lies on regulation of gene expression and how different genetic parts 
are combined to achieve certain expression outputs highlighting the role of the 5ƍ-
untranslated region (5'-UTR) due to its multiple functions in control of gene expression. 
This chapter will also explain some of the challenges associated with design and 
predictability of novel gene expression tools.  
 
1.1 Applications of bacterial recombinant gene expression  
 
1.1.1 Recombinant protein production 
 
 Many biomolecules that are of interest to the industry or academic research like 
active pharmaceutical ingredients (APIs) in pharmaceutical drugs or restriction enzymes 
for cloning are only available in insufficient quantities in nature and they needed to be 
extracted and purified from large amounts of starting material in the past. The 
development of recombinant DNA technology, however, enabled researchers to turn 
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bacteria [8] (and over time also species from all kingdoms [9,10]) into production factories 
for heterologous proteins and other biomolecules instead. As an example taken from 
academic research, structural biologists require up to several milligrams of pure proteins 
to resolve their three-dimensional structure by X-ray crystallography or NMR spectroscopy 
[11]. Independent of the final use, the basis is a suitable production host that is usually 
developed using genetic engineering strategies. The five most common expression hosts 
(based on number of registered publications) are the bacterium Escherichia coli, insect-
cell lines derived from Spodoptera frugiperda, the yeast Pichia pastoris, Chinese hamster 
ovary (CHO) cell lines and the yeast Saccharomyces cerevisiae [12]. Looking at the 
pharmaceutical market in the year 2009, when this thesis was initiated, ~39% of the 
protein-based recombinant pharmaceuticals licensed up by the Food and Drug 
administration (FDA) and European Medicines Agency (EMEA) were produced by 
mammalian cells, ~30% by E. coli, ~19% by S. cerevisiae, ~11% by hybridoma cells 
leaving ~1% to transgenic goat milk and insect cells [13]. Over half of the industrial 
enzymes were made by yeasts and molds (e.g. Kluyveromyces lactis, Saccharomyces 
cerevisiae, Aspergillus niger and Trichoderma reesei), with bacteria (e.g. E. coli and 
different Bacillus systems) producing about 30%. Animals provided 8% and plants 4% 
[14]. Finding an appropriate host for a protein production process is a multi-factorial 
challenge and the choice can be based on the requirement of the final product for 
example. The requirements can include protein yield, ability to secrete proteins, ability to 
correctly process the protein as well as time and effort required in the upstream and 
downstream processes [14]. For this work, the use of expression tools restricted itself to 
the important production host E. coli, and, as alternative hosts, both mesophilic and cold-
adapted members of the genus Pseudomonas. Therefore important applications using 
mainly E. coli and other Gram-negative bacteria will be addressed.  
 What makes E. coli and other bacteria the preferred hosts are their rapid growth 
rates, their potential to be easily modified by well-characterized genetic tools, low media 
costs and potentials to achieve high protein production levels [10]. There are examples 
described where the accumulated heterologous protein accounted for a high fraction (up 
to 50%) of the total cellular protein [15,16]. These advantages are also reflected by the 
high fraction of publications and pharmaceutical proteins produced using this host. 
Maximization strategies for recombinant protein production at the DNA level typically 
involve gene design [17], choice of a regulated promoter [18], a suitable ribosome binding 
site (RBS) [19], a fusion partner (FP) for translocation [20,21], solubility enhancement [22], 
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specific detection or affinity purification [23] and adjustment of the gene dosage [24] 
amongst others [21]. Even though there are many tools available, advanced efforts can go 
into the direction of further improvements of these parameters like optimizing an RBS 
[25,26], improving the promoter [27,28], generating more efficient transcriptional 
regulators [29,30] and stabilizing the transcript [31]. With all these potential strategies in 
mind, one can envision the complexity behind the task to maximize production of 
recombinant proteins. And these efforts do not even include protein engineering, host 
strain engineering, optimization of the fermentation conditions and downstream 
processing efforts. Process developments often start broad from the parameter 
perspective and might even involve screening of mutant libraries. Current efforts for 
overproduction of proteins either thrive to make early efforts in process development 
amenable to high throughput screening (HTS) efforts and/or to make the early stages less 
complex by narrowing down the number of variants to test in an expression cassette. 
 
1.1.2 Metabolic engineering 
  
 In metabolic engineering single enzymes, partial or even complete metabolic 
pathways are modified in an organism or even transferred from one organism to another 
to metabolize a novel compound, to create a novel product or to change the metabolic 
flow within a cell through modification of existing pathways [32]. The engineering part of 
this field is to predict which modifications to perform and to suggest a strategy to control 
the desired output. One important goal for example is to achieve a certain ratio between 
the numbers of enzymes present in a cell. This is desired in order to facilitate a balanced 
flow of metabolites through a metabolic pathway. As opposed to protein overproduction, 
metabolic engineering depends on production of adequate, not maximal, amounts of 
proteins. An important reason for this is that overexpression of certain genes within a 
pathway can cause metabolite drainage. In addition, bottlenecks can be caused for 
example when an enzyme is present in low abundance causing an intermediate product to 
accumulate (for a review see [33]). This might lead to a feedback response within the 
metabolic pathway, toxicity caused by an intermediate product or other undesired effects 
that can influence growth or the yield of the final product. To avoid imbalances, one of the 
most common strategies is to adjust the protein production levels by changing the 
regulatory elements of the expression cassette. As an example, genes coding for 
enzymes that act consecutively in a metabolic pathway can be arranged in synthetic 
operons and their expression levels can be controlled by adjusting the RBS, RNase sites 
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and the mRNA secondary structures within the intergenic regions [34,35]. Another 
successful strategy that has been applied was the coupling of different enzymes in 
appropriate ratios to a protein scaffold [36]. Whichever strategy might be chosen, this area 
of research will also benefit from advances in genetic engineering to make pathway 
engineering more rapid, less costly and more predictable in the future [37].  
 
1.1.3 Synthetic biology 
  
 Current synthetic biology applications focus on the adaptation of engineering 
principles to biological systems to understand them better, to improve cellular functions or 
to create functions that are new to nature. One approach to understand biological systems 
is to develop genetic circuits that resemble electronic networks. In these circuits, signals 
might come from the extracellular environment or even from the cell’s own metabolism in 
which case circuits were designed to form oscillators [38]. A good example for implying a 
circuit in a simple manner is one with a sensor function in which a cell is enabled to detect 
a signal from the environment and converts this event into a cellular response like 
expression of a fluorescent reporter gene. One more complex example that has caught 
attention in the scientific community is the recombinase example by Siuti et al. [39] in 
which logic and biologic memory were combined. In this case, two different input signals 
in form of two different molecules activate expression of two different recombinases. The 
respective recombinase recognition sites were placed around the genetic elements of an 
expression cassette consisting of a promoter, a terminator and a gfp reporter gene. In 
presence of the signaling molecules, the recombinases either excised or switched 
orientation of the genetic elements and thereby created a lasting effect at the DNA level. 
By arranging these elements in certain orders, different GFP readings could be observed 
depending on the logic functions implied in this gate. Despite the use of engineering 
terms, the basis is still recombinant gene expression where promoters, transcriptional 
regulators and reporter genes are connected to fulfill a logic function. Genetic engineering 
for synthetic biology application can aid in generation of more precise and reliable circuits 
by designing effector- and DNA-binding specificities of transcription factors, by modifying 
protein-protein interactions or by creating novel transcription factors with multiple 
functions. 
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1.2 The modern genetic engineering tool box with special 
emphasis on the particular tools used in this thesis 
 
 Over the past decades molecular biologists have developed a range of tools that 
represent the basis for modern genetic engineering purposes. Generally, bacteria 
harboring plasmids that contain an expression cassette (Figure 1.1) are used as 
platforms to express heterologous genes although integration of the expression cassette 
into the chromosome or cell-free expression systems without the cellular environment are 
possible alternatives [40,41].  
 
    
Figure 1.1: Overview of the arrangements of the most relevant genetic elements on 
a plasmid that can be modified to change expression of a gene of interest. 
Commonly the use of a regulated promoter is preferred. The product of the regulator gene 
(with its own promoter, 5ƍ-UTR, 3ƍ-UTR and terminator) might act positively (transcriptional 
activator) or negatively (transcriptional repressor) on transcription from the promoter. It 
binds to its own recognition sites within the promoter, upstream of the promoter or within 
the 5ƍ-UTR. A transcript is formed which consists of the 5ƍ- UTR - including the initial 
transcribed sequence (ITS) and typically a Shine-Dalgarno (SD) sequence - , the coding 
region of a gene of interest and the 3ƍ-UTR. The translated target protein might have an N-
terminal and/or C-terminal fusion partner (FP). The origin of replication determines the 
plasmid copy number and thereby the number of copies of the gene of interest. In 
bacteria, selection of the plasmid is usually accomplished by antibiotic resistance markers.  
 
I would like to stress at this point that during this thesis the term ‘ribosome binding site’ 
(RBS) will be distinguished from the term ‘Shine-Dalgarno’ (SD) sequence. RBS will be 
used to describe a region at the mRNA level which is covered by the ribosome during 
translation initiation including the SD sequence and the start codon as well as nts within 
the 5ƍ-UTR and the 5ƍ proximal end of the coding region.  
 The common arrangement of a regulated promoter, a 5ƍ-UTR, a coding region and 
a terminator can be expanded by inserting multiple coding regions under control of the 
promoter. These so-called synthetic operons are beneficial in co-expressing several 
genes in accordance with naturally occurring bacterial operons. Another extension could 
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be to subject the promoter or regulator to a more complex control mechanism like the 
combination of the T7 promoter with the lac operator in pET vectors. Further options are 
to include a second origin of replication for plasmid maintenance in other hosts (in shuttle 
vectors) or to insert elements that facilitate transfer of an expression cassette to the 
chromosome. In order to understand the function of the different genetic elements, an 
overview over the most relevant replicon types, regulated promoters and modifications of 
coding regions of a gene of interest for this thesis will be presented. 
 
1.2.1 Replicon types 
 
 Propagation of plasmids within a bacterial cell is facilitated by an origin of 
replication found on the plasmid, a replication initiation (Rep) protein which is mostly 
encoded by the plasmid as well as additional factors supplied by the plasmid and the host 
[42]. Which type of plasmid replication system is used determines the host range [43], the 
gene dosage [44], the compatibility with other plasmids [45], the stability within a bacterial 
population [46] and the heterogeneity by which the plasmid molecules are distributed 
amongst the daughter cells [47]. Concerning the host-range, there are replicon types that 
greatly rely on host enzymes during initiation and thereby often replicate in only a few 
hosts. Plasmids whose replication is initiated by host independent initiation factors on the 
other hand have a rather broad host range [42,48].  
 The mechanism by which the number of plasmids per cell is maintained directly 
determines the number of DNA copies of the gene of interest per cell which in turn affects 
the protein production level. This number depends both on the type of replicon and the 
host [49]. Interesting approaches to control the copy-number are not to use plasmids with 
a fixed range of copies per cell, but rather maintaining the plasmid at a single copy per cell 
until protein production is initiated and the copy-number is elevated [50]. 
 Maintenance of two or more types of plasmid is not uncommon in recombinant 
gene expression. Coresidence of several plasmids is desired for example for 
coexpression of chaperones [51], rare tRNAs [52] or even other genes of interest [53]. 
Essential for co-existence of several types of replicons in one cell is that these belong to 
different incompatibility (Inc) groups [54].  
 Plasmid loss is a phenomenon associated with overproduction of recombinant 
proteins from plasmids with high copy-numbers [46]. Simultaneous maintenance of a 
plasmid and overexpression of the antibiotic resistance gene and the gene of interest 
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(GOI) impose a metabolic burden on the cell redirecting cellular resources towards the 
maintenance and processing of foreign DNA [55]. A consequence of this might be 
segregational instability leading to accumulation of plasmid-free cells in a bacterial 
community that often gain a growth advantage over plasmid-containing cells. In addition to 
selection markers, plasmid stabilization elements such as the cer locus or post-
segregational killing systems like hok/sok can be inserted to ensure successful plasmid 
propagation to all daughter cells or killing of plasmid-free cells [56,57]. 
   
RK2 
 RK2 [58] and its derivatives belong to the IncPĮ group of plasmids which are 
known to replicate in a broad range of bacteria [59]. In order to make the replicon 
applicable for recombinant gene expression, the original RK2 plasmid was dramatically 
reduced in size. Derivatives of RK2, the so-called RK2-mini replicons [60], contain the 
essential elements for replication. These elements comprise the trans-acting replication 
function trfA gene encoding the replication initiation protein TrfA and oriV, the cis-acting 
origin of vegetative replication [61]. In addition these plasmids harbor the origin of transfer 
oriT which allows for the conjugative transfer of the plasmid to other microorganisms [62]. 
Host factors required for RK2 plasmid propagation in E. coli are the host initiation factor 
DnaA, the accessory HU protein, the helicase DnaB, the helicase accessory protein 
DnaC, the single stranded DNA-binding protein SSB, the primase DnaG, the DNA 
polymerase III and DNA gyrase [63,64]. The minimal replication origin oriV comprises a 
DNA region consisting of four DnaA binding boxes followed by five TrfA binding iterons, 
an AT-rich region and a GC-rich region. In order for replication to take place, TrfA and 
DnaA must bind to their respective binding sites for strand-opening at the AT-rich site to 
happen. A DnaB-DnaC complex is recruited to oriV leading to template unwinding (for 
more information, see [65]). Further details on formation of the replication complex and 
DNA synthesis are not known. TrfA has got a second important role besides replication 
initiation in which its ability to form dimers plays an important role. The handcuffing 
mechanism serves as a model to explain plasmid copy-number control. According to this 
model two RK2-based plasmids are coupled by direct interaction of iteron-bound TrfA 
molecules [61]. Thereby, further replication is inhibited through steric hindrance [65]. The 
copy-number of the original mini-RK2 plasmids is four - seven in E. coli and two - three in 
P. putida [66]. However, copy-up variants of trfA that are less sensitive to intermolecular 
coupling were identified [67] among which trfA cop271C (17-19 copies per cell [40,68]), 
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cop251M (31-33 copies per cell [68]) and cop254C (77-89 copies per cell [69]) were 
tested in our laboratories.   
 Besides the essential regions for replication, RK2 contains further control regions. 
These elements enable the plasmids to co-localize in specific subcellular positions, 
resolve multimers that are formed during replication and ensure that each daughter cell 
receives at least one plasmid copy [70,71]. Active partitioning systems encoded by E. coli 
plasmids make plasmids localize in characteristic mid- and quarter-cell positions of the 
bacterial cell while deletion of the corresponding DNA region results in random clustering 
of plasmids at the cell poles or the mid-cell position outside of the nucleoid [72,73]. The 
corresponding locus in RK2 comprises the OB1incC korB region of RK2 [70]. This region is 
able to re-establish the quarter- and mid-cell positions when inserted into mini-RK2 
replicons whereas only a marginal effect on plasmid stability can be observed. In contrast 
to RK2 namely, its minimal replicon derivatives are not stable. Stabilizing elements of RK2 
are located in the par locus consisting of two operons [71]. The parCBA operon codes for 
a plasmid multimer resolution system while a post-segregational killing system is encoded 
by parDE. Many currently used mini-RK2 plasmids [27,29,40,74] neither contain an active 
partitioning system nor the original multimer resolution system known to affect plasmid 
stabilization [75]. Under normal laboratory conditions (shake-flask cultivation, small 
inserts) in presence of antibiotic selection markers, plasmid loss has not been a problem. 
However, when cells were cultivated under high-cell density conditions in absence of 
antibiotic selection or when large DNA fragments where inserted, plasmid instability was 
observed. Therefore, insertion of the hok/sok or parDE post-segregational killing systems 
in some our mini-RK2 plasmids was performed [68,76] and plasmid stability was regained. 
It has even been hypothesized that plasmid localization might affect protein expression 
[69]. 
 
ColE1-like replicons  
 The origin of replication found in plasmid pMB1 is closely related to the ColE1 
replicon. It is also found in the well-known pBR322 plasmid [77] and commercially 
available plasmids from the pET (Novagen) and pBAD [78] series and is maintained at a 
copy-number of 15-20 per cell. Plasmids with a pMB1-based replicon can only be 
propagated in E. coli and other closely related Enterobacteriaceae. The only plasmid-
encoded factors for replication of these plasmids are the primer RNA molecule RNAII, the 
incompatibility-mediating small RNA molecule RNAI and the small repressor of primer 
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(Rop) protein with additional inhibitory functions [79]. This means that plasmid replication 
purely depends on proteins supplied by the host cell. The plasmid-encoded RNAII is the 
only one of the three factors that plays a direct role in replication. It binds to a DNA region 
close to the origin of replication and this DNA-RNA hybrid serves as a substrate for 
RNaseH. RNaseH in turn cleaves RNAII and thereby forms a mature primer molecule for 
DNA polymerase I action. The remaining steps of initiation, melting and unwinding of the 
dsDNA, protection of single stranded DNA, elongation from the RNAII-based primer and 
termination are carried out by the host replication machinery. RNAI has a role in regulating 
the frequency of plasmid replication by hybridizing with the RNAII primer precursor and 
thereby blocking the RNAII-DNA binding. Rop influences the formation of RNAI-RNAII 
hybrids and thereby also functions as a copy-number control factor. Plasmids with a 
pBR322-derived replicon are believed to be distributed by random partitioning and were 
lost to a great extent under non-selective conditions [80,81].  
 
 
1.2.2 Regulated expression systems 
 
 To be able to influence the timing and amount of expression, a heterologous gene 
is often placed under control of a regulated promoter. There are many different systems 
available in order to express genes in bacteria. Due to the many different expression 
purposes (section 1.1), there is no ideal expression system on the market that has got all 
the desired qualities. Among the number of available systems, however, there are a few 
that were of particular interest for this work and these will be described in the following 
sections. The focus here is on the promoter and how expression from the promoter is 
controlled. Characteristics of the 5ƍ-UTR and typical ribosome binding sites will be 
addressed later. 
 
XylS/Pm 
 Pm is a positively regulated promoter that originates from the P. putida pWWO 
plasmid. This plasmid encodes proteins involved in the catabolism of aromatic 
hydrocarbons [82] and Pm controls transcription of one of two operons found on this 
plasmid. Inducibility of transcription from Pm is mediated by the transcription factor (TF) 
XylS. In nature, expression of xylS is controlled at two levels; constitutive low-level 
expression from the weak Ps2 promoter and hyperexpression from the strong and 
regulated Ps1. The Ps1 promoter is activated by aromatic hydrocarbons which bind to the 
TF XylR, the second regulator of the benzoate degradation pathway. This protein 
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dimerizes in presence of inducer leading to activation of transcription from Ps2 [82]. In 
most of our in-house vectors, however, regulation of xylS expression was simplified by 
deleting the Ps1 promoter meaning that xylS expression is not further regulated [60] 
(Figure 1.2). 
 
 
 
 
Figure 1.2: Schematic representation of the key DNA elements of the XylS/Pm 
expression system as found in the in-house set of vectors. The gene coding for the 
positive regulator XylS is constitutively expressed from the weak Ps2 promoter. XylS can 
dimerize upon inducer binding and is thereby enabled to bind to two adjacent XylS-binding 
sites (XBS). The -10 and -35 Pm core promoter elements are recognized by ı32 and ı38 
factors. The Pm 5ƍ-UTR region includes a SD sequence involved in translation initiation. 
The bidirectional transcription terminator rrnBT1T2 prevents any influence on transcription 
from Pm caused by transcription from other upstream promoters.  
 
 The XylS N-terminal domain (NTD) is responsible for inducer binding, establishing 
physical contact with the RNA polymerase Į-subunit and facilitating dimerization 
[83,84,85,86] while the XylS C-terminal domain (CTD) makes contact with the DNA 
binding sites one of which overlaps with the -35 element of Pm [87]. The second layer of 
regulation of gene expression from Pm is accomplished by the involvement of different 
sigma factors depending on the growth phase. ı32 (ıH) binds to Pm in the early 
exponential phase and ı38 (ıS) in the late exponential or stationary phase [88].  The 
XylS/Pm system has been used successfully for different expression purposes ranging 
from overproduction of medically relevant proteins [20,68] and metabolic pathway 
engineering [89] to identification of novel FPs for the target protein [90,91]. Parts of this 
system have also been subjected to random mutagenesis and these comprise the 
regulator gene xylS [29], the Pm promoter core region [27] and the DNA region 
corresponding to the 5ƍ-UTR [25,74,89] (Figure 1.3). The underlying screening procedure 
to identify the xylS, Pm and Pm 5ƍ-UTR variants was based on expression of the bla gene 
(coding for ȕ-lactamase) [92]. Varying expression of this gene leads to different amounts 
of the ȕ-lactamase product and thereby causes the host cell to tolerate different amounts 
of the antibiotic ampicillin. It could be demonstrated that bla expression levels correlate 
quite well with the ampicillin concentration the cells tolerate [25,90]. E. coli strains 
harboring the xylS, Pm and Pm 5ƍ-UTR mutant libraries were grown on agar plates with 
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increasing ampicillin concentrations and clones with for example the highest tolerance 
were picked and subjected to further analysis.  
 
 
Figure 1.3: Sequence of the DNA region covering the Pm core promoter with its -10 
and -35 elements, the distal and proximal XylS binding sites and the DNA region 
corresponding to the 5ƍ-UTR. In the in-house vectors, a unique restriction site (PciI) was 
introduced at the 5ƍ-end of the UTR DNA region to facilitate exchange of the Pm- and Pm 
5ƍ-UTR DNA fragments that were randomly mutagenized. Pm and Pm 5ƍ-UTR variant 
elements can be conveniently combined using XbaI plus PciI and PciI plus NdeI, 
respectively. The transcriptional start site is marked with +1, the SD sequence is 
highlighted with a box and the nts making up the start codon at the mRNA level are typed 
in bold (derived from [25,27,87]).  
 
 
 In case of xylS, the gene was mutagenized using an error-prone PCR strategy 
followed by random shuffling of selected mutations. Target mutants stimulated 
transcription from Pm and thereby increased expression of the downstream gene bla. The 
novel XylS variants all contained substitutions in the NTD of the protein and two of them 
(XylS-StEP11 and –StEP13) could stimulate ampicillin tolerance 9.5 times compared to 
the wild-type in presence of inducer accompanied with a 4-times increase of the 
uninduced tolerance level. Pm promoter variants were identified using a different 
mutagenization strategy. A 24-bp region around the -10 element was replaced with an 
oligonucleotide mixture with a high doping frequency of the wild-type nt and low 
frequencies for the other three nts [25,74,93]. Screening for high ampicillin tolerance led to 
the identification of Pm variants that could enhance ȕ-lactamase production by a factor of 
14 [27]. A corresponding method was applied to randomly mutagenize the original Pm 5ƍ-
UTR. Expression of bla could be increased up to 7-fold at the transcript level and up to 20-
fold at the functional protein product level [25]. At the other end of the scale, Pm 5ƍ-UTR 
variants leading to reduced (down to 1.5% of the wild-type) ȕ-lactamase production were 
identified [89]. A further way to increase expression from XylS/Pm is to place xylS under 
control of a different, stronger promoter and to supply the xylS gene in trans on a separate 
plasmid [94].  
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 Advantages of this system are that the inducer is cheap, that inducer uptake is 
passive, that expression from XylS/Pm is activated in an inducer dose-dependent manner 
that this system can function in several bacterial species and that background expression 
is low when wild-type elements are used [95]. However, substantial leakiness can be 
observed when variant elements of Pm, the Pm 5ƍ-UTR, xylS or combinations of these are 
used [40].  
 
AraC/PBAD 
 The AraC/PBAD system is one of the most commonly used systems in recombinant 
gene expression and the pBAD series of vectors is commercially available (Invitrogen; 
[78]). The AraC protein acts both as an activator and repressor. Just like XylS, AraC 
consists of two domains, one responsible for DNA binding and one for effector binding 
and dimerization [96,97]. In absence of inducer, an AraC dimer is formed which connects 
the O2 binding site found within the araC gene and the I1 site found in the PBAD promoter 
region (Figure 1.4) thereby forming a DNA loop [98,99]. AraC also regulates its own 
expression [100] at two levels; one comprises AraC binding to two O1 half-sites within PC 
which prevents transcription from this promoter and the other the above mentioned DNA 
looping process. AraC works as an activator protein in presence of L-arabinose, the signal 
which leads to rearrangement of the AraC dimer towards I1 and I2 binding and subsequent 
transcription from PBAD.  
 
 
Figure 1.4: Overview over the DNA regions that make up the AraC/PBAD system for L-
arabinose- induced expression of a gene of interest. Transcription of the araC gene is 
controlled by the PC promoter (derived from [97,101], Invitrogen). Genes under control of 
AraC/PBAD are transcribed by the host-cell RNAP. Control of the system is achieved by 
AraC binding to different recognition sites; I1 and I2 in close proximity to the PBAD core 
promoter -35 element, two O1 half-sites in PC and one O2 half site located within the araC 
gene.  
 
 The third role of AraC is the regulation of expression of L-arabinose uptake 
systems [97] which makes regulation of AraC/PBAD even more complex compared to 
XylS/Pm. L-arabinose enters the cell by active transport catalyzed by two transporters, 
one high-capacity, low-affinity L-arabinose transporter [102] and one high-affinity 
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transporter [103]. The glucose concentration in the growth medium adds a second level of 
control [104] which is mediated by cAMP and its receptor protein CRP. The CRP 
recognition site overlaps with the I1 half-site. Low glucose levels coincide with high cAMP-
CRP levels the complex of which can interact with the CRP DNA binding site to help 
rearrange AraC-binding to promote expression from PBAD. Moreover, CRP positively 
stimulates PC.  
 Consequences of the complex regulation of AraC/PBAD reveal themselves at 
different levels. On the one hand tightness of the system is ensured which makes this 
system popular for expression experiments especially when leakage and subsequent 
toxicity would impair high production levels. At the same time, the promoter is strong 
enough to be used in protein overproduction and is even precisely adjustable when 
controlled expression for improved soluble expression is desired [78]. Disadvantages of 
the system are connected to catabolite repression and inducer uptake. In the former case, 
the important carbon source glucose, commonly used in growth media affects expression 
from AraC/PBAD. In the latter case, the necessity for active inducer uptake leads to the all-
or-nothing induction phenomenon which causes extensive heterogeneity of expression in 
cell populations. Adjustments of the expression system to render it more homogenous 
included L-arabinose transporter engineering [102,105]. Other modifications of the system 
were performed [106,107], but not as systematic as for XylS/Pm with exception of a more 
recent pursued strategy applied by a Danish iGEM team in 2011 [108]. 
 
LacI/PT7lac 
 Even more heavily used among the expression systems is LacI/PT7lac found for 
example in pET vectors (Novagen) [21]. It contains elements from the T7 system (T7 
polymerase and its promoter) and elements from the lac promoter system (lacI repressor 
gene and its promoter, lac operator sequence). Supplying the T7 polymerase gene is 
usually accomplished by using an E. coli host strain with a chromosomally integrated T7 
gene 1 (encoding the polymerase) for example under control of the L8-UV5 lac promoter 
(E. coli BL21(DE3) cells, Invitrogen) or the PBAD promoter (E. coli BL21-AI™ cells, 
Invitrogen). LacI serves as a repressor by forming homotetramers that make contact with 
the operator sequence lacO 1 in the 5ƍ-UTR DNA region preventing T7 polymerase from 
binding to its promoter (Figure 1.5). In presence of an inducer like IPTG however, LacI 
dissociates from the lac operator making room for T7 RNAP. The mechanism of T7 RNAP 
binding to its promoter differs from the way E. coli RNAP established contact with a 
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promoter. In contrast to E. coli RNAP which consists of six subunits the T7 enzyme 
consists of only a single unit that recognizes a stretch of 17 bps without the requirement of 
host ı factors [109]. 
 
 
Figure 1.5: Depiction of the plasmid-borne genetic elements of the LacI/PT7lac 
system. To make the system complete, a T7 polymerase gene needs to be supplied in 
trans from a further plasmid, a phage or the bacterial chromosome. Note the absence of 
typical E. coli -10 and -35 core promoter elements. The T7 RNAP recognizes a promoter 
sequence that is rather distinct from the E. coli consensus promoter making transcription 
from PT7lac very selective.  
  
 This system is probably the one which underwent most development due to the 
many known problems associated with protein overproduction using it. A major drawback 
is the high leakiness which can be attributed to the removal of regulatory elements found 
in the natural lac system like the CRP binding site in direct proximity to the promoter 
controlling expression of the target genes or further lacO sites [110]. Reduction of 
leakiness was addressed by introducing T7-lysozyme-encoding plasmids to the cells, the 
inhibitor of T7 RNAP [111]. Slight reduction of basal expression can also be achieved 
when using E. coli strains with ȜDE3 lysogens due to the remaining responsiveness to 
catabolite repression despite the introduction of mutations within the L8-UV5 lac promoter 
that led to decreased sensitivity to glucose [112]. Another disadvantage is the high cost of 
the inducer IPTG. Costs can be reduced by using auto-induction media [113]. In spite of 
the efforts, some problems remain, namely the decoupling of transcription and translation 
[114], mutation of the T7 RNAP gene in the host strain [115] or limitation in cell growth 
associated with the high productivity of this system.  
 
LacI/Ptrc 
 LacI/Ptrc is a second example for an expression system containing a lac promoter 
derivative (Figure 1.6). For once, both lac core promoter elements have been modified. 
The -10 regions in the  Ptrc promoter stems from the lac UV5 promoter which distinguishes 
itself from the natural lac promoter -10 region by two nts [110] making it a strong TATAAT 
site. The -35 region was taken from the trp promoter [116]. One further modification was 
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included in pTrc vectors, namely a mutation within the lacI promoter (lacIQ) leading to 
increased lacI transcripts and thereby stronger production from Ptrc. 
 
 
 
Figure 1.6: Schematic representation of the DNA regions forming the LacI/Ptrc 
expression system. Most control elements from the natural lac promoter (CRP binding 
site, two additional lacO sites) have been removed. 
 
 Using this system, E. coli cells could accumulate up to 30% of the total cellular 
protein and it is generally regarded as a strong system [117]. However, leakiness is a 
drawback of this system which again can be attributed to lack of control mechanisms on 
top of repression via LacI4-lacO. It is therefore not recommended to use LacI/Ptrc for 
expression of toxic genes. The second disadvantage, namely the high costs of the IPTG 
inducer, can be circumvented by using temperature-sensitive mutants of LacI. Effects of 
the heat-shock response on the bacterial cell caused by elevated temperatures though 
needs to be kept in mind.   
 
 
1.2.3 Genes of interest and their encoded protein products 
 
 Proteins represent the most important products of recombinant expression projects 
[12]. On top of regulation of gene expression by using certain promoter systems, the 
coding region, the amino acid sequence and the encoded function need to be considered 
to find a good production strategy. An often employed means is gene design which has 
become widely applicable today due to reduced costs and which serves different 
purposes [118]. Gene design is a term used to describe the modification of the coding 
region of a protein using synonymous mutations in favor of better expression output. 
Factors that are considered in gene design make use of the degeneracy of the genetic 
code and change the nt sequence in favor of the host’s codon preference or GC content, 
for removal of unwanted sequences like restriction sites, repeats or promoter-resembling 
sequences and for reducing mRNA secondary structures [17]. More details on control of 
translation initiation and elongation will follow in section 1.3.2. A strategy that involves 
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modification of the final amino acid sequence is the use of FPs at the target protein’s N- or 
C-terminus. FPs can lead to solubility enhancement and/or tagging for simplified detection 
and affinity purification and typical examples are small ubiquitin-like modifier (SUMO), 
maltose-binding protein (MBP), glutathione-S-transferase (GST), thioredoxin, N-utilizing 
substance A (NusA), histidine tags of different lengths and the c-myc epitope tag. A 
further use of an N-terminal tag is general expression enhancement for example by 
displacing unfavorable secondary structure elements in the ribosome binding site 
[91,119]. Third, FPs for secretion of recombinant proteins to the periplasm are commonly 
used for minimization of inclusion body (IB) formation, reducing chances for protease 
degradation or improved disulfide bond formation. Yet another advantage of using a FP is 
the correct processing of the N-terminus by either automatic removal of the partner via the 
translocation machinery or use of specific protease recognition sites [120]. More drastic 
approaches are the redesign of the protein like deletion of complete domains [121].  
 
1.2.4 Genetic tools for DNA modification 
 
 Current advances in cloning technologies speed-up the upstream stage of a 
recombinant protein production process by saving hands-on work, by enabling 
simultaneous connection of several DNA elements, by avoiding dependence on restriction 
enzyme recognition sites and expensive enzymes or combinations of these. Although 
traditional restriction cloning using type II restriction enzymes is still common (e.g. 
BioBricks [122], BglBricks [123] and Standard European Vector Architecture (SEVA; 
[124])) other methods have gained interest to standardize, parallelize and simplify 
connection of several different DNA fragments. Examples for a current cloning method 
includes use of type IIs restriction enzymes as in Golden Gate cloning [125]. This 
technique relies on single-cutters that cut outside the recognition sequence. Techniques 
that do not require restriction enzymes were also refined within the past years and include 
Gateway cloning using Ȝ recombination [126] or the ligation-independent cloning (LIC) 
techniques Circular Polymerase Extension cloning (CPEC; [127]) and Isothermal 
Assembly (Gibson method; [128]) amongst others. Another very versatile, quick and easy 
LIC method is one-step sequence- and ligase- independent cloning (SLIC) [129] (Figure 
1.7) which was also relevant for this thesis. 
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Figure 1.7: Schematic representation of the one-step sequence- and ligase- 
independent cloning (SLIC) method to connect several DNA fragments. Derived from 
Jeong et al [129]. 
 
 
1.2.5 Bacterial hosts 
 
 The bacterial cell creates the environment for the process of recombinant gene 
expression and it thereby influences the yield and quality of the protein product. E. coli is 
still one of the dominant production platforms [130]. E. coli strains have been engineered 
to meet certain requirements for recombinant protein (over)production. These cover 
combinations of characteristics for plasmids maintenance, expression and protein product 
quality where changes have been made either via chromosomal modifications or the 
addition of plasmids. Strains for modified expression in general include those that are 
deficient in Lon and OmpT proteases, those that co-express chaperones like DnaK, DnaJ, 
GroES, GroEL, Skp or ClpB which aid in folding of the target proteins and prevention of 
aggregation, those that create a reducing cytoplasmic environment for disulfide bond 
formation using glutathione reductase- (gor), glutathione synthetase- (gshA) and 
thioredoxin reductase- (trxB)  deficiency and those that co-express tRNAs for rare codons 
 18
for improved translation efficiency (reviewed by Makino et al. [131]). Particular efforts on 
strain development have been performed for use of pET expression vectors and include 
integration of the T7 RNAP gene into the chromosome under control of different 
promoters (section 1.2.2), addition of a gene encoding for T7 lysozyme or mutant variants 
of the LacY transporter for improved dose-response to IPTG [21]. Besides these classic 
strains, more modern approaches have been pursued for E. coli. Some highlights were 
the integration of post-translational modification machineries via insertion of pathways for 
N-glycosylation of eukaryotic proteins [132] or an enzyme responsible for acetylation [133] 
and the insertion of non-natural amino acids into proteins for expansion of the genetic 
code [134]. Other interesting engineering strategies were the generation of RNAseE-
mutant strains for increased mRNA longevity (Invitrogen) or global strains engineering 
approaches [135]. 
 A second bacterial host that was used in this thesis to study expression from 
XylS/Pm was P. putida KT2440, a strain cured for the TOL plasmid. Besides 
overproduction of proteins [136], this strain is utilized for bioremediation, production of 
fine-chemicals, bioplastics [137] and is currently studied to further exploit its metabolic and 
biotechnological capacities (Victor de Lorenzo’s lab at CNB, Madrid, Spain [138]). A great 
advantage of this host is the compatibility with our in-house vectors (expression system 
and replicon-type), ease of genetic manipulation and biosafety. 
 
1.3 Regulation of gene expression 
 
 Once a genetic construct is made and transferred to the host strain more complex 
regulatory mechanisms than encoded by the expression system itself act on expression of 
the gene of interest. To put it simple, the flow of genetic information during gene 
expression starts with transcription of the DNA region between the promoter and the 
transcriptional terminator into mRNA. The flow continues with translation of information 
encoded by the coding region into a protein which then maturates into its active state to 
fulfill its function. The process ceases with degradation of both transcript and protein. 
However, it is important to remember that for prokaryotic organisms such as E. coli the 
translation process is initiated as soon as the newly formed transcript 5ƍ-end protrudes 
from the RNA polymerase. Also there is direct physical contact between the elements of 
transcription and translation involved. Furthermore, several RNAP complexes can 
transcribe one coding region and a multitude of ribosomes translate the information from 
 19
one transcript into several proteins simultaneously. At the same time, mRNA degradation 
might occur while translation takes place. All of these steps are highly regulated and there 
is no linear relationship between the number of genes of interest, mRNA and protein in the 
cell at a given time point due to complex regulatory mechanisms [139]. However, there is 
no doubt that changing one of the processes also has an impact on the following 
processes. In the following sections, the fundamental processes of transcription, 
translation and mRNA degradation are explained. These give a foundation for discussing 
challenges and pitfalls in genetic engineering approaches.  
 
1.3.1 The process of transcription and its regulation 
 
 The transcription process can be divided into three major steps. During the first 
step, RNA polymerase binds to the promoter and initiates transcript formation. The 
second step involves processive elongation of the newly formed mRNA while termination 
is the third and last step. Among these, initiation of transcription is regarded as the key 
step in regulation of gene expression due to the possibility to prevent excessive transcript 
formation at an early stage and thereby limiting the use of cellular resources at 
subsequent stages [140]. The first prerequisite for transcription initiation to occur is the 
correct positioning of the core RNA polymerase at the core promoter -10 and -35 
elements (and occasionally an extended -10 or an upstream promoter (UP) element) 
facilitated by ı-factors [141]. Depending on the promoter, different ı-factors (ı70, ı38, ı32, 
ı28, ı24, ı19 (ı70 family) and ı54 (ı54 family)) are involved in promoter recognition [142] 
among which ı70 is the one responsible for transcription of house-keeping genes and ı38 
and ı32 for stress-induced genes such as genes under control of Pm (see section 1.2.2). 
In this context, cellular stress can refer to entering the stationary growth phase (ı38), heat-
shock and subsequent accumulation of unfolded proteins (ı32) or presence of certain 
chemicals like benzoic acid derivatives. As far as Pm is concerned the ı-factor recognition 
sites are not specific for ı38 or ı32and transcription can take place in several growth 
phases [88]. In addition to the essential ı-factors, transcription factors belonging to the 
two general classes of activators or repressors determine whether transcription takes 
place or not. Action of these classes of DNA binding proteins is facilitated by small ligands 
which might be referred to as environmental stimuli in general or inducers in recombinant 
gene expression [143,144]. Another level of complexity is added when TFs possess dual 
functions which can occur naturally such as in AraC (section 1.2.2) or artificially such as in 
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engineered LacI variants [145]. One further way of RNAP action modulation occurs via 
proteins that establish direct contact with RNAP, but lack DNA binding domains [146]. 
Following the first contact of the RNAP holoenzyme with a specific promoter sequence, an 
open complex is formed [147]. This happens spontaneously at ı70–dependent promoters, 
while the action of enhancer-binding proteins is required for ı54–dependent promoters 
[143]. The process of open complex formation is characterized by opening and unwinding 
of the double-stranded DNA around the promoter and up to +2 relative to the 
transcriptional start site followed by repetitive synthesis and release of abortive transcripts 
with a length of up to 15 nts [148,149]. The part of the DNA region corresponding to the 5ƍ-
UTR that matches the length of the abortive transcripts is called initially transcribed 
sequence (ITS). During the initiation phase, RNAP unwinds the DNA template while still 
being attached to the promoter which requires a pulling action, a phenomenon known 
under the term of DNA scrunching [150]. However, at some point, RNAP escapes the 
promoter and transcription enters the elongation phase. It is believed that ı-factors (at 
least ı70) remain attached to the transcription machinery. How many full-length transcripts 
are formed relative to the amount of abortive transcripts is termed promoter escape 
efficiency. Termination of transcription is mediated in one of two ways. One way is protein-
factor independent and involves intrinsic terminators which are hairpin structures that form 
in GC-rich DNA stretches which are followed by a stretch of U residues [151]. The other 
way is factor-dependent and requires a protein like the major termination factor Rho and 
its recognition sites (see [152] for more information). 
 
Points of transcriptional control  
 Sequence-specific determinants for transcription initiation efficiency are not only 
found in the promoter region itself, but also reach further downstream. Naturally, promoter 
core elements, extended promoter recognition regions (extended -10 and UP elements) 
and other transcription factor binding sites themselves play a role in transcription initiation 
because their nt composition determines the affinity by which DNA binding domains of the 
TFs make contact with their specific recognition sites [153,154,155]. This is often referred 
to as basal promoter strength [143]. On top of that the distance between these sites is of 
importance as well as the composition of nts surrounding them. During transcription 
initiation, DNA bending takes place which is part of the correct positioning of the elements 
of the transcription initiation complex with respect to each other [121,156]. Changing the 
nt composition affects the flexibility of the DNA region and thereby affects the 
arrangement of the protein factors. Second, transcription involves unwinding and melting 
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of the double-stranded DNA which affords different amounts of energy depending on the 
nt composition [157,158]. Upon release of the initially formed transcript from its template, 
binding energies between the DNA:RNA hybrid might play a role (Jørgen Skancke, 
personal communication) just like in the elongation phase [140]. Not only is the DNA 
region in direct proximity to the promoter important for transcription initiation, but also the 
part of the DNA region corresponding to the 5ƍ-UTR which lies beyond the initially 
transcribed sequence. The mechanism for this is unkown [25].    
 Other control mechanisms influence the elongation stage. For once the 
composition of nts in the DNA region corresponding to the mRNA determines the 
evenness of the polymerization speed [159]. The course of elongation is namely prone to 
compete with alternative pathways [140]. One alternative to elongation is pausing caused 
by transcriptional arrest signals encoded in the DNA sequence [160,161]. Biological 
functions for transcriptional pausing include the control of the overall rate of mRNA 
formation, the interaction with external factors and coordination of transcription and 
translation (more details follow in section 1.3.4) [161,162,163]. Sequence elements that 
are involved in pausing include promoter-like regions that are recognized by ı70 
[164,165,166]. A second and third alternative is editing and pyrophosphorolysis, 
processes which allow for correction of mis-incorporated nts through removal of a short 
oligonucleotide stretch or a single nt, respectively [140]. However, the rate of transcription 
elongation as a whole is believed to depend on the initiation efficiency [167,168]. Several 
RNAP complexes can transcribe from the same promoter and act positively on one 
another by pushing backtracked RNAPs forward given that transcription initiation is 
efficient enough.  
 Besides the DNA sequence, the polymerase itself determines the rate of 
transcription. Elongation happens at a speed ranging from 20-200 nts/s. More efficient 
transcription can be achieved by using a foreign RNAP. A prominent example is the T7 
RNAP which catalyzes the coupling of ribonucleotides at a rate five- eight times faster 
than the E. coli host cell RNAP [21,114]. 
 
1.3.2 The translation process and its regulation 
 
 Translation of the information encoded within an mRNA occurs in the four steps of 
initiation, elongation, termination and ribosome recycling all of which are well-understood 
in bacteria thanks to decades of genetic and biochemical studies, including 
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crystallographic studies [18,169,170,171]. Initiation involves the assembly of the 
preinitiation complex (PIC) consisting of the mRNA, the 30S ribosomal subunit, initiation 
factors (IF1, IF2 and IF3) and the initiator tRNA fMet-tRNAfMet. The first codon-anticodon 
interaction between the start codon (e.g. ATG) and the fMet-tRNAfMet takes place. The 
50S ribosomal subunit then loosely connects with the PIC, but GTP hydrolysis mediated 
by IF2 establishes a more stable 70S initiation complex (IC). One by one IF dissociates 
from the 70S IC and the elongation phases commences (summary derived from [170]) 
involving the two elongation factors (EF-G and EF-Tu) and the non-canonical factor EF4 
(LepA) [172]. During elongation a constant of exchange of tRNAs within the ribosome 
takes place. Each tRNA is transferred from the acceptor A site in the ribosome to the 
peptidyl P site and the exit E site while new peptide bonds are formed. In this way, the 
transcript slides through the ribosome until the stop codon is reached. Translation 
termination is mediated by three release factors (RF1, RF2 and RF3) and dissociation of 
the ribosome requires additional proteins (ribosome release factor and IF3) [173]. The 
factors involved in translation are recycled at this stage and used in subsequent 
translation events. 
 
Regulation of translation 
 Gene expression is highly regulated at the post-transcriptional level [174]. As for 
transcription, the initiation stage of translation is also regarded as the rate-limiting step. By 
changing translation initiation for example, protein production levels could be varied over 
two orders of magnitude [175]. The mRNA features that influence translation initiation 
have been summarized in an experimental review [176]. Obvious sequence features that 
affect translation are the kind of start codon, the length of the SD sequence, the distance 
between the SD sequence and the start codon, the position and strength of secondary 
structure elements in form of hairpins and the presence of an A/U-rich enhancer 
sequence. Sequence features that result in high expression levels are the use of an ‘AUG’ 
or ‘GUG’ start codon and stem-loop structures upstream of the SD-sequence or 
downstream of the start codon. Concerning length of the SD sequence and position 
relative to the start codon (measured as the distance between the center of the SD 
sequence and the first nt of the start codon), choice of a 8/7 or 6/10 SD sequence (length 
SD/distance to start codon) is of benefit for an efficient translation initiation.  
 Another perspective to our current understanding of transcription initiation involves 
initiation of translation in absence of the SD sequence. Only 57.1% of the E. coli genes 
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possess an SD sequence [177]. One way to explain why translation initiation in absence 
of SD sequences is possible is that absence of secondary structures around the start 
codon is sufficient to support ribosome binding. Initiation sites that promote translation in 
absence of an SD sequence contain an A/U-rich stretch devoid of stable secondary 
structures [169]. Moreover, presence of upstream-hairpins can have a positive effect by 
redirecting base-pairing motifs away from the initiation site. However, a conflicting theory 
exists which suggests that this unstructured region close to the start codon alone is not 
sufficient for translation initiation. Instead, it is believed that an SD sequence further 
upstream is required which is brought in proximity to the start codon via folding of the 5ƍ-
UTR [178]. Additional factors that regulate translation at the initiation stage are small 
RNAs like in the hok/sok post-segregational killing systems, metabolites found in 
riboswitches and temperature. Riboswitches are defined as elements within a 5ƍ-UTR that 
are able to bind diverse metabolites and thereby repress or activate gene expression at 
the transcriptional and translational level [179].  
 In the elongation phase, pausing can be observed which is either attributed to 
pairing of internal SD sequences with the anti-SD sequence [180] or simply reduction of 
the translocation rates due to presence of rare codons [181]. By making use of the 
degeneracy of the genetic code, the nts in the coding sequence can be changed in favor 
of high translational efficiencies. SD-like sequences can be removed by using 
synonymous codons that interrupt this region. Mostly, a coding sequence is changed by 
introducing more frequently used codons, but it has been shown that introduction of rare 
codons at the 5ƍ-end of the coding region (ramp theory) might lead to a more even 
distribution of ribosomes across the transcript by prevention of jamming [182]. 
 
1.3.3 Mechanisms of mRNA degradation and its regulation 
 
 At the same time as information encoded by an mRNA is translated into protein, 
mRNA degradation takes place. RNA degradation involves the action of ribonucleases 
(RNases) which can either cut internally (endonucleases) or attack the RNA from the 
termini (5ƍ- or 3ƍ- exonucleases) as well as accessory proteins performing 5ƍ- and 3ƍ-end 
modifications. The enzymes involved in mRNA degradation are often organized in a 
multiprotein complex called degradosome. Important enzymes found in E. coli that act 
mainly from the 3ƍ-end are RNaseE, an endonuclease that targets A/U rich single stranded 
regions and commonly initiates mRNA decay, polynucleotide phosphorylase (PNPase), 
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RNase R and RNase II, three different 3ƍ-exonucleases that require single stranded RNA 
and work in response to RNaseE action as well as poly(A) polymerase which couples 
adenines to the 3ƍ-end of a stem-loop and thereby promotes its resolution and subsequent 
degradation [183,184,185]. The enzyme complex acting from the 5ƍ-terminus contains 
RNA pyrophosphohydrolase which cleaves off pyrophosphate and which physically 
interacts with RNaseE and thereby enhances this enzyme's catalytic activity to cut the 
mRNA further downstream [186].  
 Generally speaking, the number of transcripts per cell affects the number of 
encoded proteins. Therefore, regulation of mRNA degradation is crucial for the fate of a 
transcript. Half-lives of bacterial mRNAs range from s to several min [187,188] making it a 
labile molecule. However, the turnover can be modulated in favor of a higher stability. 
Bacterial mRNAs have some intrinsic properties that ensure certain stability. For once, the 
triphosphate at the 5ƍ-end stabilizes a transcript. Furthermore, translating ribosomes 
simply act by sterically hindering RNases from binding to their target. In addition, self-
interaction of mRNA plays a vital role in particular at the 5ƍ-end of the transcript and both 
existing as well as willingly introduced stable stem- loop structures can protect the mRNA 
from being degraded to a certain degree. Another major stem-loop structure can often be 
found at the 3ƍ-end. Further control points involve the interplay between translation and 
transcription which will be explained below.  
 
1.3.4 Transcription:translation coupling and its impact on transcript turnover 
 
 Several translation events can occur on one transcript, as has already been 
visualized by Miller et al. in 1970 [189] and translation is initiated co-transcriptionally. This 
means that changes affecting transcription also affect translation, especially in the rate-
determining initiation step. Besides their connection to mRNA, direct physical contact 
between the transcription and translation machinery is established through protein 
interactions. The NusG TF is considered to be the central coupling factor between 
transcription and translation [190,191]. This protein is able to interact both with the RNA 
polymerase via its amino-terminus and the TF NusE via its carboxy-terminus (identical to 
the ribosomal S10 protein found in the 30S subunit). NusG has an important role in 
transcription elongation where it suppresses transcriptional pausing, involves in 
transcription antitermination, prevents backtracking of RNAP and consequently increases 
the elongation rate [161,192,193]. These functions are observed in translated transcripts. 
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In absence of translating ribosomes, however, NusG is able to bind to the Rho protein by 
which it exerts its role in transcription termination [194]. Another Nus factor with a dual 
function is NusA. Together with other Nus-factors this protein is involved in formation of 
stable ECs. Its second and major involvement, however, is in intrinsic termination due to 
the ability to recognize pausing and termination signals. 
 Understanding the structural basis for transcription:translation coupling gave rise to 
an updated version of the traditional schematic illustration of the translation process. The 
traditional view was that the transcription rate determines the speed by which ribosomes 
travel across the transcript. According to an updated model the speed of the ribosomes 
determines the processivity of transcription elongation not vice versa [195,196]. Moving 
ribosomes can accelerate RNAP. Absence of translating ribosomes on the other hand e.g. 
caused by rare codons stalls the TEC waiting for the ribosomes to connect with the RNAP 
again [197]. Alternatively, premature termination is induced in case translation is 
abolished e.g. by amino acid starvation. Considerations to why the two processes are 
coupled in bacteria are for once that the coupling prevents that non-functional transcripts 
accumulate in the cytoplasm [198]. Secondly, it is hypothesized that tightly coupled 
transcription and translation minimizes the chances for de novo DNA:RNA hybrid 
formation, so called R-loops, during transcription. However, uncoupling of the two 
processes can be observed [114].  
 A second important relation is the impact of translation on transcript stability. Iost 
and Dreyfus could demonstrate experimentally that efficient translation stabilizes a 
transcript [199]. This study supports earlier studies in which antibiotics targeting 
translation were utilized to study how translation inhibition affects mRNA stability 
[200,201]. In general, reducing translation initiation efficiency by introducing mutations 
around or within the SD site and thereby reducing the affinity of a ribosome to the 
translation initiation site destabilizes a transcript [202] and vice versa [203,204]. One 
accepted explanation is that translating ribosomes mask RNase sites, in particular within 
the 5ƍ-UTR [205]. Interestingly, factors involved in translation and mRNA degradation 
share similar recognition sites. An A/U rich stretch around the SD sequence both leads to 
an unstructured region that promotes ribosome binding [206,207] and is associated with 
RNase E binding [208] implying that the binding affinity of the two factors has an impact 
on the fate of an mRNA [209]. Not only is ribosome binding around the SD sequence 
important for mRNA stability, but also the general distribution of translating ribosomes 
across the coding region [210]. 
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 How efficiently a protein is produced also depends on the amounts of ı factors, 
RNAP, nts, ribosomes, tRNAs, amino acids, energy equivalents amongst others available 
at the location of gene expression within the bacterium. Due to limited availability of the 
mentioned resources and high packing density of the molecules in the bacterial 
cytoplasm, excessive expression of a gene can lead to local depletion of resources 
[211,212] restricting total protein production. It has been hypothesized that better 
distribution of gene copies in a cell e.g. accomplished by high copy number plasmids that 
are randomly spread in the cytoplasm makes use of cellular resources more efficient 
which in turn leads to better protein production per gene copy [69].  
 
 
1.4 Challenges during combination of genetic elements with    
focus on the central role of the 5ƍ-UTR 
 
 A central goal of genetic engineering is to influence expression of a gene and 
thereby change production of the encoded protein product. Although engineering of the 
host-cell RNAP and other global changes of the transcription machinery to generate 
different cellular phenotypes are possible [213,214], more specific approaches to focus on 
a gene or a set of genes are desired. Over the past decades, it has become clear that 
gene expression involves a sequence of complex and highly regulated steps and that in 
order to gain control over the outcome of gene expression more than simply combining a 
promoter, a regulator, a 5ƍ-UTR, a coding region and a terminator is necessary. This is of 
particular importance when even more complex tasks than expression of a single gene 
are pursued such as engineering of whole metabolic pathways (section 1.1.2) or 
generation of regulatory circuits (section 1.1.3). The DNA region corresponding to the 5ƍ-
UTR is of special importance due to its involvement in transcript formation, transcript 
degradation and translation. Currently, single genetic parts for design or redesign of 
systems are available which are often combined in a ‘plug-and-play’ manner to study gene 
expression [215]. Owing to complex regulatory mechanisms, however, these single parts 
can not be treated as context-free meaning that the function of the connected parts can 
not be purely derived from the sequence of the single parts alone. This leads to 
unpredictable effects on expression.  
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Table 1.1: The complex role of the 5ƍ-UTR in gene expression. Positions of the nts are 
given relative to transcriptional start site (+) or to the translation start codon (-).  
 
Process Part of 5ƍ-UTR Involvement Source 
Transcription nt +1 and +2 
 
nt +1 to +15 
 
nt +10 to +24 
 
variable 
 
 
nt -20 to -1  
 
 
whole sequence 
Initial melting during initiation 
 
Promoter escape 
 
Unknown 
 
Repression of transcription (e.g.  
lacO/ LacI interaction) 
 
Backwards effect from translation  
to transcription 
 
5ƍ-UTR secondary structure formation: 
- Premature termination mediated  
by metabolite binding  
[141] 
 
[148,149]
 
[74] 
 
 
 
 
[196] 
 
 
[216] 
Translation nt -20 to -1 incl.:  
 
- SD sequence 
 
- Spacing SD-start 
codon  
 
- secondary structure 
elements 
 
whole sequence 
 
Translation initiation: 
 
- Pairing with 16S rRNA 
 
- Positioning of 30S complex 
 
 
- Availability of RBS (SD, start  
codon) 
 
5ƍ-UTR secondary structure 
formation in riboswitches: 
- translation inhibition by metabolite 
binding (RNA, small molecules)a 
[217] 
 
 
 
 
 
 
[218] 
 
 
[216] 
Transcript 
degradation 
RBS 
 
 
A/U-rich regions 
 
5ƍ-PPP 
 
 
secondary structure 
elements 
Indirect effect on transcript stability 
through variable translation efficiency 
 
Degradation mediated by RNase E  
 
Protection from direct 5ƍ-> 3ƍ 
degradation 
 
Stem loops at 5ƍ-end protect from 
degradation 
[206] 
 
 
 
[208] 
 
 
[219] 
 
[203,220]
 
a A special role of the 5ƍ-UTR is found in riboswitches and aptamer technology where 
external signals such as temperature, metabolites or proteins apart from the general 
expression machinery act on expression of a gene by influencing transcription or 
translation [216].  
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 The influence that the parts have on each other has earlier been defined as 
‘context dependency’ [221] and ‘part-junction-interference’ [222]. In case of the 5ƍ-UTR, its 
influence can be seen from the perspective of its position within a stretch of DNA. To be 
more specific it forms the direct linear link between a promoter and a coding region 
(compositional context). But it is also subjected to the cellular environment with in trans- 
influence from external factors (host context; e.g. growth phase, strain) whose metabolism 
is influenced by the environmental context (e.g. temperature, pH, [221]). Some of the most 
relevant roles of the 5ƍ-UTR in regulation of expression were already mentioned in the 
previous paragraphs. However, since this region was a topic of particular interest in this 
study, the key roles are summarized here (Table 1.1). Because of this complex role, 
choosing one particular 5ƍ-UTR for expression of one gene probably does not have the 
same effect on expression of another gene due to the interference with the 5ƍ-proximal 
coding region [218,223]. It has been proposed to physically separate the RBS from the 
remaining part of the 5ƍ-UTR by insulators [222,224] that contain elements that mediate 
cleavage of the 5ƍ-UTR to get a better control on the expression output. And indeed, these 
RNA-processing strategies led to the design of more predictable systems since relative 
strengths of promoters could be maintained for different genes by adjusting the RBS. To 
make this adjustment, both computational methods and experimental strategies are 
available. 
 Computational tools for prediction of expression levels and design of novel 5ƍ-UTR 
elements are the RBS calculator [225], the RBS designer [226] and the UTR designer 
[227]. On the other hand, screening of mutant libraries is still a common approach 
[74,175]. Generally, strategies to improve expression by focusing on translation initiation 
are successful and their usefulness can be backed-up by the latest findings on 
transcription:translation coupling (section 1.3.4). However, they neither cover the 
complete regulatory space nor lead to complete reliability of expression output. That is 
why more complex set-ups to address control of transcription and translation were 
generated in form of combining regulatory element libraries including different promoters 
and RBS [228]. These examples show that there still is groundwork to be done by 
molecular biologists to get a deeper understanding of gene expression that can be used in 
more targeted rational design of biological systems.    
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2 Aims of the study 
 
The XylS/Pm system has been studied extensively over a long period of time in our 
research group. At the onset of this PhD work we knew that at least some proteins could 
be expressed at very high (industrial) levels with this system and that it in addition had 
certain unusual attractive properties such as broad host range and fine-tuning capacity. 
The group has tried to exploit this potential both for maximization of recombinant protein 
production and for metabolic engineering purposes, however, just like with other 
expression systems, results were often unexpected. In this PhD work the focus was to 
study the influence of different genetic and physiological parameters on recombinant 
protein production and to contribute knowledge on how to achieve a more controlled 
expression output. The specific goals were as follows:  
x Many different bacterial expression cassettes are used in parallel in academia and 
industry, but we felt that there was no way of objectively comparing the 
performances of these systems based on the available scientific literature. It was 
therefore decided to set up a study which would allow a comparison of the core 
elements of commonly used expression cassettes, namely their regulated 
promoters, and systematically comparing their features directly in the same 
genetic background (replicon and host). 
x The DNA regions corresponding to the 5ƍ-UTR downstream of the various 
promoters are very different, but they can in principle be substituted in any 
promoter system. Since it is well established that 5ƍ-UTR DNA sequences can 
have a profound effect on the total expression outcome we wanted to exploit the 
potential of designing 5ƍ-UTR sequences that would work efficiently in the XylS/Pm 
system. The 5ƍ-UTR design would be based on the idea that these sequences are 
important both for transcription and translation, and that these sequence features 
could be separated and optimized individually. 
x A further genetic parameter that is known to affect recombinant protein production 
is the plasmid backbone. Characteristics of XylS/Pm would be determined by 
variation of the replicon type, plasmid copy-number and presence of plasmid 
stabilization elements.  
x The XylS/Pm system would be utilized to control production of toxic proteins to 
analyze the effects of different host growth conditions (physiological parameters) 
on recombinant protein production.  
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x The last influence studied during this project would be the choice of bacterial host 
strain and the nature of the chosen mini-RK2 plasmid backbone containing the 
xylS/Pm system allows for the direct transfer of the vectors to different hosts like 
Pseudomonas in cases where E. coli might not be the suitable expression host.  
This in-depth analysis of the promoter systems would hopefully lead to more general 
findings that could be applied for future recombinant expression strategies both to 
maximize protein production and to control expression at any desired level.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 31
3 Summary of results and discussion 
 
 The core of this thesis is represented by the work on the positively regulated Pm 
promoter and its associated 5ƍ-UTR region (Figure 3.1). Many findings are published in 
Papers I-III, but this section also supplies further (unpublished) data and discusses them 
with respect to recent developments published in scientific journals. 
 
 
Figure 3.1: Visual representation of the topics covered by this thesis. The work in 
this thesis focused on recombinant gene expression in Gram-negative bacteria mainly 
using XylS/Pm, but also alternative regulated promoter systems with the goal to minimize 
trial-and-error attempts in the development of a protein production process. The 
abbreviations stand for: ITS - initially transcribed sequence, SD - Shine-Dalgarno 
sequence, RBS - ribosome binding site, R - regulator gene, P - promoter, U - 5ƍ-UTR, GOI 
-gene of interest, T - terminator, ori - origin of replication, Abr - antibiotic resistance 
marker. Notice that for this thesis, RBS is defined as a stretch of ribonucleotides which is 
covered by the ribosome during translation initiation meaning that it includes the SD 
sequence, the start codon and also nts around these regions both within the 5ƍ-UTR and 
the 5ƍ proximal end of the gene.  
 
Within the following chapters, the most relevant results covering different approaches 
will be described and discussed. The first subchapter focuses on the results from a 
systematic comparison of features of commonly used regulated promoter systems at the 
transcript and protein level performed in E. coli. In the following chapter, work on the DNA 
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region corresponding to the 5ƍ-UTR is summarized. This work involved random 
mutagenesis, rational and generic design approaches to study the complex role of this 
region at the transcriptional and translational level. Next, the work in this thesis also 
included studies on the influence of the plasmid backbone and the growth conditions 
(physiological parameters) on recombinant gene expression in E. coli (third and fourth 
subchapter). At last, the use of alternative bacterial hosts for recombinant expression 
under control of XylS/Pm was evaluated, namely P. putida and cold-adapted 
Pseudomonas strains (fifth subchapter).  
 
3.1 A systematic study on the influence of different regulated 
promoter systems on recombinant protein production 
 
 Regulated promoters represent one important genetic key element to control gene 
expression. Despite the large number of such promoters available on the market, there 
are a few that are heavily used in heterologous expression in Gram-negative bacteria. 
These all have certain advantages and disadvantages making it impossible to name a 
system that is best for any purpose. Each of these promoter systems is often part of a 
certain expression vector like LacI/PT7lac in pET vectors, XylS/Pm in pJB vectors, 
AraC/PBAD in pBAD vectors or LacI/Ptrc in pTrc vectors. Certain promoters even require a 
specific bacterial host like LacI/PT7lac which requires an E. coli strain supplying a T7 
polymerase gene. It is known that the genetic context (like the plasmid copy-number), the 
bacterial host or transcriptional terminators influence expression which means that a 
comparison of the features of regulated promoters from different vector backbones and 
hosts is not suitable to truly evaluate the characteristics of one promoter with respect to 
another. Surprisingly, comparisons among different promoter systems had only been 
performed using different vector backbones or describing features at a theoretical level 
when this work was initiated. And during the course of this work, only one systematic 
study had been published using LacI-regulated systems [229]. In this study the 
performances of different regulated promoters were compared by using carefully designed 
vectors that functioned as test systems for early stages of protein production (Paper I).  
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3.1.1 Design of a set of expression vectors enabling comparison of bacterial 
promoter systems 
 
The first step of the vector development was to define the 'regulated promoter' 
DNA region and it was decided to extract the regions corresponding to the promoter, the 
5ƍ-UTR, the regulator gene and its promoter as well as the region between the regulator 
and the promoter including additional control elements (like CRP in pBAD) from 
commercial vectors and transfer this device to a common vector backbone. It would have 
been possible to also pick a common 5ƍ-UTR region or at least a common RBS within the 
5ƍ-UTR for all promoters. However, it is known that there is a context dependency 
between the promoter and the 5ƍ-UTR DNA region meaning that variations within the DNA 
regions corresponding to the ITS of the 5ƍ-UTR DNA region can affect transcriptional start 
site selection and level of active target protein [25,230]. To ensure that the correct 
transcriptional start site was maintained and that the lacO region in two of the promoter 
systems (lacI/PT7lac and lacIQ/Ptrc) was unchanged with respect to the promoter and the 
remaining downstream 5ƍ-UTR DNA region, it was decided to keep the 5ƍ-UTR DNA 
regions that were found in the original vectors. I also made sure that all coding regions 
started with 'ATG' and that gene sequences optimized for E. coli were used ensuring that 
expression was not limited by an unfavorable coding region (e.g. presence of rare codons, 
transcriptional pausing signals, strong mRNA secondary structures). For some 
commercial vectors like pET or pBAD, it is possible to insert genes of interest via a 
multiple cloning site (MCS). By using alternative restriction sites within an MCS different 
RBS are created changing the spacing and sequence composition between a SD 
sequence and a start codon. However, these sequence modifications can affect 
translation initiation and indirectly affect protein production [170,218]. Due to this, the 
default RBS present in pET16b, pBAD/gIII_calmodulin, pTrc99A and pTA16, respectively, 
was picked (see Paper I; Methods or 3.2.1 below). Common for all four 5ƍ-UTR DNA 
regions was a slight modification just upstream of the start codon where the ‘CATATG’ 
site (for NdeI) was introduced. The well-known context dependency between a 5ƍ-UTR 
and the 5ƍend of a coding region was not part of this comparison and was analyzed in 
separate studies (Paper II and unpublished data).  
Another important consideration was with respect to which variant of the XylS/Pm 
system to choose. In our group, mutant variants of the regulator XylS [29], the Pm 
promoter core region [27] and its cognate 5ƍ-UTR region [25] had been identified earlier 
leading to improved gene expression. One important reason why a promoter variant of 
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Pm, not a XylS or a Pm 5ƍ-UTR variant, was chosen in this comparative expression study 
of regulated promoter systems was that uninduced expression levels were only increased 
by a factor of ~2 (vs. ~4.3 (XylS) or ~7.5 (5ƍ-UTR)). Another reason was that enhancement 
achieved by Pm promoter variants was less gene-dependent than achieved by a 5ƍ-UTR 
variant. In total, the DNA regions from the regulated promoters of lacI/PT7lac, lacIQ/Ptrc, 
xylS/Pm and araC/PBAD as well as a high level expression variant of Pm, Pm ML-1-17, 
were utilized and a set of 60 vectors was constructed (five promoter systems, two 
replicons, six GOI). Comparative expression studies using vectors containing the 
lacI/PT7lac, lacIQ/Ptrc, xylS/Pm and xylS/Pm ML-1-17 regions were performed in E. coli 
ER2566 (T7 polymerase 1 gene positive) and studies using vectors with the araC/PBAD, 
xylS/Pm and xylS/Pm ML-1-17 systems in E. coli DH10B (ara negative). For more details 
see Paper I.  
 
3.1.2 Systematic study on the influence of the chosen regulated promoter 
systems on accumulated transcript and protein levels 
 
Part of a systematic comparison was to find a good basis for evaluating the 
characteristics of the regulated promoters with respect to each other. Within recombinant 
expression, several steps during biosynthesis of proteins are important and these cover 
transcript accumulation, translation into recombinant protein in total as well as the fraction 
of soluble and active protein produced. These aspects differ from one another such that 
not all transcripts might be translated into protein [231] and that different forms of the 
protein might be present in the cell (folded vs. unfolded, processed vs. unprocessed, 
active vs. inactive protein). In recombinant protein production, it is generally desired to 
maximize the amount of folded, soluble, processed and active target protein which could 
be measured directly in case of reporter proteins or purified and used for more complex 
functional studies. Achieving this goal does not necessarily mean that expression should 
be pushed to the possible maximum, but requires a certain balance between efficiency of 
expression and ability of the protein to achieve its folded and active state instead [232]. 
One way to influence expression levels is to use different regulated promoter systems and 
the systematic comparison of some selected ones led to the following findings. 
First, LacI/PT7lac led to accumulation of the highest amount of transcript among the 
systems which was rather expected due to the very efficient T7 RNA polymerase [233]. 
However, the apparent advantage of this promoter system was not reflected at the protein 
activity level. When relative protein activity was compared among the different promoter 
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systems namely, it became evident that the XylS/Pm ML1-17 system was nearly as strong 
as or even slightly stronger than LacI/PT7lac.  
A second important observation was made when transcript data were correlated to 
the total amount of recombinant protein produced (soluble and insoluble protein fractions 
from protein gels together). According to the data, the excess of transcript produced by 
LacI/PT7lac was in fact translated, but a distinct or even major fraction was accumulated as 
insoluble protein. This was especially evident for luciferase. For all the proteins studied, 
LacI/PT7lac led to the highest accumulation of insoluble protein, but was also the system 
which was most likely to produce most total recombinant protein (Paper I, Figure 3). In 
some occasions, it might even be preferred to continue to work with the insoluble fraction 
in the downstream process, especially when this fraction makes up the major part of 
recombinant protein for example or when a protein is prone to aggregate and it is possible 
to refold the protein (Paper III). XylS/Pm and LacI/Ptrc generally led to the least amount of 
total protein. However, the ratio between soluble and insoluble protein was higher 
compared to the two stronger promoters XylS/Pm ML1-17 and LacI/PT7lac.   
 The interesting finding that luciferase tended to form insoluble aggregates when 
overexpressed led to the question whether the PBAD promoter would have a similar effect 
as LacI/PT7lac. Characteristics of the AraC/PBAD system in relation to XylS/Pm and XylS/Pm 
ML1-17 at the transcriptional and translational level were performed in a different E. coli 
strain, DH10B, which is unable to catabolize L-arabinose (Figure 3.2).  
 
 
Figure 3.2: Luciferase production analysis in E. coli DH10B (unpublished data). Cell 
lysates from recombinant strains were subjected to qPCR (A), protein activity 
measurements (bar diagrams in B) and protein gel analysis (gel pictures of soluble and 
insoluble fractions in B). All data were related to the XylS/Pm system (values arbitrarily set 
to 1).  
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 Data collected in this E. coli strain generally confirmed that it is more beneficial to 
use XylS/Pm ML1-17 compared to XylS/Pm which became evident from accumulated 
transcript data, activity data and the protein gel analysis. Although AraC/PBAD led to a 
slightly higher amount of accumulated transcript compared to XylS/Pm ML1-17, similar 
amounts of active and soluble luciferase were detected. Virtually all recombinant 
luciferase was present in the soluble protein fraction. 
  
3.1.3 Recommended applications of the regulated promoter systems in 
heterologous gene expression 
 
 To evaluate which of the promoter systems was the most suitable for expressing 
heterologous genes depends on the scope. If the goal is to produce as much protein in 
general, LacI/PT7lac would be the system of choice. In this case, the efficient transcription 
is of advantage. In some cases, like shown for scFv173-2-5-AP, expression might be 
limited at the transcription stage and an efficient T7 polymerase was able to compensate 
for this limitation. For this protein efficient transcription was also beneficial for the soluble 
fraction of recombinant protein. Not coincidental, the LacI/PT7lac system is the dominant 
promoter system used for recombinant protein production e.g. based on the total number 
of publications in the worldwide Protein Data Bank (wwPBD) data set, in which use of pET 
vectors is described [12]. On the other hand, if the amount of active protein is of higher 
importance, XylS/Pm ML-1-17 or AraC/PBAD might as well be used. It is known that 
transcription and translation are coupled in bacteria [198] and my results indicate that 
these two systems maintain a better balance between transcript accumulation and 
translation indicating a better use of cellular resources. In contrast, the excess of 
transcript produced by LacI/PT7lac can be interpreted by an uncoupling of the two 
processes. A third criterion would be the ratio between soluble and insoluble protein. 
Judged from the protein gels, a ratio in favor of soluble protein was achieved using 
XylS/Pm, AraC/PBAD and LacI/Ptrc, in some occasions also XylS/Pm ML1-17. In a previous 
study, expression from different negatively regulated promoters was compared in a direct 
manner, similar to this study [229]. Data collected by this group suggested that the 
weakest promoter tested (the lacUV promoter) produced the highest fraction of soluble 
protein, but that LacI/PT7lac sill produced the highest amount of soluble protein in total 
followed by LacI/Ptrc. This finding could be confirmed. At the same time more data were 
contributed which indicate that the use of the Pm promoter variant Pm ML1-17 or 
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AraC/PBAD would yield similar amounts without producing excessive amounts of transcript. 
An alternative to a regulated promoter system that can be used to fine-tune expression 
levels is the rhamnose-inducible RhaR-RhaS/rhaBAD system [95]. RhaR-RhaS/rhaBAD is 
either utilized to control expression of T7 lysozyme to serve as additional control element 
for the LacI/PT7lac system (Lemo system; Xbrane Bioscience AB), but also for recombinant 
protein production directly ([234,235]; Lucigen). This trend supports the idea of 
incorporating several regulated promoters in a portfolio of bacterial expression systems in 
order to maximize chances to achieve high expression levels; at least one system like 
XylS/Pm for proteins that require careful adjustment of expression levels (see Paper III) 
and one system like LacI/PT7lac for easy to express proteins which can comprise a high 
fraction of the total cellular protein without forming insoluble aggregates or affecting cell 
physiology noticeably. Further findings and recommendations for expression purposes 
beyond maximization of recombinant protein production are summarized in Paper I, Table 
3. 
 
3.2 Demonstration of the complex role of the 5ƍ-UTR DNA region in bacterial 
recombinant expression  
 
 Several genetic parts of the expression systems influence efficiency of 
transcription and translation and thereby the amount of target protein. Besides promoter 
strength and RNA polymerase efficiency, the nt composition of the 5ƍ-UTR DNA region 
influences the processes of transcription and translation. A tool to evaluate the sequence 
of a 5ƍ-UTR DNA region with respect to translation initiation efficiency is the RBS 
calculator [218]. This tool is based on a biophysical thermodynamic model for translation 
initiation. It takes into account the region around the SD sequence and the 5ƍ proximal 
coding region and calculates translation initiation rates (TIRs). TIRs were calculated for 
the regions around the 5ƍ-UTRs of the different promoter systems and the 5ƍ proximal 
coding region transitions of the five different genes used in order to compare strengths of 
the RBS (Paper I, Figure 5). Due to the complexity of the regulation of the steps involved 
in protein biosynthesis, it was challenging to evaluate the actual effects of the calculated 
TIRs on expression of the different genes in most cases. That is why it was decided to 
extract the 5ƍ-UTR DNA region as a part and to study effects of the region alone on gene 
expression to get a deeper understanding of its multiple roles and to open up new 
possibilities for rational design. 
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 A body of scientific evidence has been collected in the past decades 
demonstrating the versatile and complex role the 5ƍ-UTR in recombinant gene expression 
(section 1.4). Previous findings in our group showed that creation of mutant libraries 
covering the 5ƍ-UTR and screening made it possible to identify Pm 5ƍ-UTR expression 
variants which either led to decreased or increased final protein product levels compared 
to the wild-type 5ƍ-UTR sequence. In other words, mutagenization and screening could be 
applied to cover a big expression window simply by mutating this DNA region. This was 
possible because the mutations that were inserted into the Pm 5ƍ-UTR DNA region 
affected both transcription and translation [25,74,89]. However, screening combinatorial 
libraries had certain disadvantages. For once, the effects the mutations had on gene 
expression were quite gene-dependent. As an example, the LII-10 Pm 5ƍ-UTR variant led 
to ~20-fold increased ȕ-lactamase production, but only ~1.5-fold increased 
phosphoglucomutase and luciferase production. Also, mutations were spread over the 
entire 5ƍ-UTR DNA region which made it impossible to identify specific mutations that 
either led to increased transcript accumulation or translation efficiency. For future genetic 
engineering approaches, however, a more reliable, less gene-dependent and less time-
consuming method to adjust a 5ƍ-UTR DNA region to improve expression levels would be 
desired. Using the Pm promoter and its cognate 5ƍ-UTR DNA region as a model system, 
the goal of designing a sophisticated 5ƍ-UTR region was approached in three steps during 
the PhD project. The first was to verify the actual need to design better 5ƍ-UTRs for 
expression by comparing different strategies to improve a 5ƍ-UTR DNA region (3.2.1). 
Second, a successful attempt was made in identifying Pm 5ƍ-UTR DNA sequences that 
either affected transcription or translation (3.2.2). Third, a novel 5ƍ-UTR region was 
designed in which the knowledge from previous 5ƍ-UTR modification attempts was applied 
(3.2.3). 
 
3.2.1 Evaluation of different strategies to increase gene expression by 
changing the 5ƍ-UTR DNA region  
 
 Despite the knowledge about the role of the 5ƍ-UTR region in gene expression, it is 
still common practice to clone a gene behind a promoter and its associated 5ƍ-UTR or a 5ƍ-
UTR with generally good features with respect to translation initiation without making 
adjustments in favor of a good 5ƍ-UTR - 5ƍ-coding region context. In order to demonstrate 
the need to make more rational choices when it comes to connecting 5ƍ-UTRs and coding 
regions, it was decided to compare different strategies to improve a 5ƍ-UTR with respect to 
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expression levels. We hypothesized that 5ƍ-UTR DNA sequences identified by screening 
would lead to higher expression levels than simply using 5ƍ-UTRs with strong RBS. To test 
this hypothesis the 5ƍ-UTR regions from the regulated promoter systems studied in the 
previous section (Table 3.1B) were extracted and transferred to mini-RK2 plasmids 
containing xylS/Pm replacing the original Pm 5ƍ-UTR DNA region.  
 
Table 3.1: Sequences of the 5ƍ-UTR variants that were used to compare their effects 
on bla expression. The SD sequences are written in bold face, the PciI (= BspLU11I) site 
at the 5ƍ-end (not present in B) and the NdeI site at the 3ƍ-end at underlined. The nts 
corresponding to the start codon are double underlined and the nts deviating from the Pm 
wt 5ƍ-UTR DNA sequence are highlighted in grey, except for the sequences depicted in B 
which differ both in length and sequence composition.  
 
  A Pm wt 5ƍ-UTR DNA sequence 
 
           Pm wt          AACATGTACAATAATAATGGAGTCATGAACATATG 
 
  B 5ƍ-UTR DNA sequences present in commercially available promoter systems (Paper I) 
 
           PT7lac           GGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTT 
          TGTTTAACTTTAAGAAGGAGATATCATATG 
           Ptrc          AATTGTGAGCGGATAACAATTTCACACAGGAAACAGACCATATG 
           PBAD          ATACCCGTTTTTTGGGCTAACAGGAGGAATTACATATG 
  
  C Pm 5ƍ-UTR up variants that mainly act on transcription (and translation to a lesser   
      extent) [25] 
 
  Pm LV-1       AACATGTACCATTATAACGGAGTAATGAACATATG 
  Pm LV-2       AACATGTACCATAATACAGGAGTTATGAACATATG 
 
  D Pm 5ƍ-UTR up variants that on transcription and translation [25,40] 
 
   Pm LII-10      AACATGTACCACAATAATGGAGTTTTGAACATATG 
   Pm LII-11      AACATGTTACACAATAATGGAGTAATGAACATATG 
   Pm H39         AACATGTACCATAATAATGGAGTCTTGAACATATG 
 
  E Pm 5ƍ-UTR down variants that on translation causing decreased expression [89] 
 
  Pm DI-3        AACATGTGGCATAATAATGGAGTTATGCACATATG 
  Pm DI-7        AACATGTACAATGATTATGGAGTCATGTACATATG 
   Pm DI-8        AACATGTCCCATAATAATGGAGTCATGAACATATG 
 
  F In silico-designed 5ƍ-UTR DNA sequences with maximal TIR (same length as Pm 5ƍ- 
     UTR) (Paper II) 
 
   dIB1           AACATGTTCGTCTTCACGCTAAGGAGGTACATATG 
  dIB2           AACATGTTACTTATACGAGGAGGTTACAGCATATG 
   dIB3           AACATGTACCGTTCTTTCTAAGCGAGGTTCATATG 
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 Two of the three regulated promoter systems (LacI/PT7lac and AraC/PBAD) contained 
stronger RBS than the XylS/Pm system independent of the coding sequence while the 
one present in the LacI/Ptrc 5ƍ-UTR was either only slightly stronger or even weaker than 
the RBS present in the Pm 5ƍ-UTR dependent on the 5ƍ-proximal end of the coding region 
(Paper I, Figure 5). Another way to improve translation initiation is to apply rational design 
tools to find the 5ƍ-UTR DNA sequence that allows for the most efficient translation 
initiation given a certain coding region. The different strategies to improve a 5ƍ-UTR were 
tested using bla as reporter gene due to the ability to use ampicillin tolerance of a cell as 
direct output for bla expression (section 1.2.2). Using this gene also has the advantage 
that expression levels can be varied over two orders of magnitude [25,89]. Previously, it 
could be shown that some combinations of Pm promoter and Pm 5ƍ-UTR variants could 
have an additive effect on each other [40]. This time, the Pm 5ƍ-UTR in plasmids with the 
Pm wild-type or Pm ML1-17 promoter was replaced with PT7lac, Ptrc and PBAD 5ƍ-UTRs and 
resulting ampicillin tolerance levels were determined. Data analysis revealed that for the 
Pm wild-type, 5ƍ-UTRs from the three alternative regulated promoter systems caused 
higher ampicillin tolerance than the Pm 5ƍ-UTR (Figure 3.3A). However, for the Pm ML1-
17 promoter, it was different. The Pm promoter variant enhanced ampicillin tolerance five 
times. This increase was only exceeded by the effect of the PT7lac UTR (7-fold), not the Ptrc 
and PBAD 5ƍ-UTRs (four- and two- fold, respectively). Replacement of the Pm 5ƍ-UTR with 
so-called UTR up-variants (Table 3.1C and D) led to even further increase of bla 
expression which exceeded 13-times improvement compared to the wt Pm 5ƍ-UTR 
(Figure 3.3B). The DI UTR variants (Table 3.1E) on the other hand lowered ampicillin 
tolerance by a factor of 10 to 33. As could be assumed, the designed UTR variants with 
optimal features with respect to translation initiation (Table 3.1F) did improve bla 
expression. However, with only four- to eight- fold improvement of ampicillin tolerance 
compared to the Pm 5ƍ-UTR, it was concluded that the screened up variants of the Pm 5ƍ-
UTR still were the best choice to achieve the highest bla expression improvement based 
on changing the 5ƍ-UTR.  
 A different way of interpreting the data was to look at whether expression levels 
could have been predicted based on sequence analysis (Figure 3.3C). For the Pm 5ƍ-UTR 
DI variants, lowered TIR values compared to the wild-type sequence coincided with 
lowered tolerated ampicillin concentrations. This supported previous experimental data 
which revealed that these UTR variants down-regulate translation [89]. Despite this it 
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would not have been possible to predict expression levels based on sequence analysis. 
This is especially evident for LV-1 and LII-11, two Pm 5ƍ-UTR variants that only had a 
slightly increased TIR value compared to the wild-type (1.3- and 1.5- fold higher), but 
which could increase ampicillin tolerance by a factor of ~12. The mutations within these 
Pm 5ƍ-UTR variants are known to affect transcript accumulation in addition to translation.  
 
 
Figure 3.3: Analysis of the effects of different 5ƍ-UTR DNA sequences on bla 
expression based on ampicillin tolerance testing and theoretical analysis of the 
RBS. A and B Results from ampicillin tolerance testing of strains expressing bla from Pm 
(or Pm ML1-17) in dependence of different 5ƍ-UTR DNA sequences. Expression was 
induced with 2 mM m-toluate. Values represent the highest ampicillin concentration at 
which growth was observed. Error bars point to the next highest ampicillin concentration 
that inhibited growth. 13 g L-1 was the highest concentration used. The different Pm 5ƍ-
UTR variants were published before: LV-1, LV-2, LII-10 and LII-11 [25]; H39 [40]; DI-3, -7, 
-8 [89]. The three latter sequences led to tolerance of 0.03, 0.06 and 0.10 g L-1 ampicillin, 
respectively, under the given conditions. dIB1-3 were designed by the RBS calculator 
[218]. Ampicillin tolerance levels of LII-10 vary because two slightly different plasmid 
backbones were used: pTA16=pSB-M1b (A) and pIB11 (B) (difference in two restriction 
sites around the xylS gene; otherwise same sequence around Pm, Pm 5ƍ-UTR DNA 
sequences and GOI. C Calculated TIRs obtained by analyzing UTR-bla DNA regions with 
the reverse engineering function of the RBS calculator. (Paper II and unpublished data) 
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 Another example is designed 5ƍ-UTR dIB1 which has a 207-fold higher TIR value 
than the Pm 5ƍ-UTR, but which led to only 3.8-fold improvement of ampicillin tolerance. 
This analysis demonstrated the need to understand the sequence-determinants that affect 
transcription and translation better in order to be able to choose or re-design a 5ƍ-UTR in a 
more predictable manner for example by utilizing RBS design tools.  
 
  
3.2.2 Attempts to identify specific mutations within Pm 5ƍ-UTR DNA 
sequences that influence transcription or translation  
 
 The comparison between the different 5ƍ-UTR DNA sequences described above 
highlighted that screening was the preferred method to identify such sequences with 
respect to high expression. The analysis also revealed that the high expression levels 
achieved by the Pm 5ƍ-UTR variants could not have been predicted based on sequence 
analysis. This could be attributed to the fact that mutations within these variants lead to 
increased transcript production and translation efficiency at the same time. This means 
that a prediction method purely based on translation-influence was not sufficient to 
evaluate the potential of 5ƍ-UTR DNA sequences to enhance protein production levels. 
The extent to which the mutations found in the 5ƍ-UTR variants stimulate one or the other 
process differs. Mutations in LII Pm 5ƍ-UTR variants for example are believed to mainly act 
on translation while mutations in LV Pm 5ƍ-UTR variants probably confer mainly increased 
transcript production [25]. Earlier, two artificial operon constructs had been created, pAO-
Tn and pAO-Tr [236]. These were applied to generate mutant libraries to get a better 
insight into which mutations lead to stimulation of either of the processes, not a mixture 
(Paper II).  
 
Novel artificial operon constructs to identify Pm 5ƍ-UTR DNA sequences that either 
lead to increased transcript accumulation or protein production 
 
 The short description of how the artificial operon libraries were made and screened 
in order to identify novel Pm 5ƍ-UTR variants is the following. First, a doped synthetic 
oligonucleotide mixture covering the central Pm 5ƍ-UTR region (see Table 3.1A) was 
inserted into pAO-Tr and pAO-Tn using the PciI and NdeI sites. By not randomizing the 5ƍ-
UTR DNA core region completely, but by using a low substitution frequency for each 
position instead (14.4% substitution by a different nt versus 85.6% wild-type nt) a certain 
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resemblance to the original Pm 5ƍ-UTR was assured. This rendered the mutated 5ƍ-UTR 
DNA sequences variants of the Pm 5ƍ-UTR instead of completely new 5ƍ-UTRs. In 
previous 5ƍ-UTR random mutagenesis studies, the SD was also included in the 
randomized region. However, the mutations causing high expression did not affect the 
original four nt long SD sequence [25] which is why the SD sequence was kept intact in 
the mutant library. The resulting Tr- and Tn-UTR libraries (UTR libraries derived from 
pAO-Tr and pAO-Tn, respectively) where then transferred to E. coli and transformants 
were selected on agar plates supplemented with kanamycin. Several 100,000 clones were 
pooled and subjected to agar plates containing m-toluate and different ampicillin 
concentrations (for details, see Paper II). Strains growing on high ampicillin 
concentrations were picked and tested phenotypically again (ampicillin tolerance). 
Plasmids were isolated from strains tolerating high concentrations and transformed back 
into E. coli. 5ƍ-UTR DNA regions found in strains whose phenotype could be confirmed 
were then sequenced. The 5ƍ-UTR DNA regions were re-synthesized as pairs of 
complementary oligonucleotides and cloned back into pAO-Tr or pAO-Tn. Finally, the 
constructs were transferred to E. coli one last time for ampicillin tolerance testing.   
 Among the five novel UTR variants identified from the Tr-UTR library, there were 
three (r31, r36 and r50) which could lead to the same level of ampicillin tolerance as 
caused by mutations contained in LV-1 and LV-2. Mutations in the previously identified 
LV-1 and LV-2 Pm 5ƍ-UTR variants could lead to increased tolerance to ampicillin (about 
4-fold) when inserted upstream of celB. This could be attributed to increased transcription 
of the operon because increased translation of celB would not influence translation of bla 
in a direct manner. This effect was expected because these two Pm 5ƍ-UTR variants were 
proven to mainly cause transcript accumulation of a target gene [25].  The 5ƍ-UTR variants 
all differed in their sequence. Three variants had a different total length (r28, r31 and r50). 
However, the number of novel Tr-UTR candidates was generally low and three rounds of 
screening needed to be performed. None of the Tr-UTR variants led to higher ampicillin 
tolerance than the previously identified variants. Although more clones with mutations in 
the Tr-UTR variant were identified in the initial screen, they could not be confirmed in later 
stages suggesting that mutations in other places than the Pm 5ƍ-UTR DNA region led to 
increased ampicillin tolerance. Indeed, during the second screening round mutations 
within the second codon of celB (CCC-> T/UCC) were detected in more than half of the 
sequenced constructs and additional mutations were detected within the PciI and NdeI 
restriction sites. And these were only the mutations that could easily be identified. Similar 
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to the novel Pm 5ƍ-UTR variants that could finally be confirmed, LV-1 and LV-2 were also 
identified in the same genetic context meaning that the Pm 5ƍ-UTR library was placed 
directly preceding the celB gene. The only difference was that celB and bla were 
translationally fused by an overlapping start and stop codon. The celB gene was 
previously shown to be well-expressed in presence of the wild-type Pm 5ƍ-UTR already. 
This means that both screening tools (the one described here and the one developed by 
Berg et al. [74] potentially led to identification of the mutations within the Pm 5ƍ-UTR with 
the strongest effect on celB expression. No clear positional hot-spot was observed and 
there was not any mathematical tool available to analyze the sequence composition of a 
5ƍ-UTR DNA region with respect to transcription initiation available. That is why analysis of 
the 5ƍ-UTR variants was performed at the transcript and protein level (see below).  
 Compared to the Tr-UTR library, screening of the Tn-UTR library led to the 
identification of more Pm 5ƍ-UTR variants and in two screening rounds 22 variants were 
confirmed in the end. These caused up to 25 times increased ampicillin tolerance 
compared to the wild-type. During screening of the Tn-UTR library, some strains with even 
higher ampicillin tolerance were found. But when the DNA region between the Pm 
promoter and the celB was sequenced, it turned out that three Pm 5ƍ-UTR DNA fragments 
had been inserted; two fragments in regular orientations interspersed with a third in the 
inversed orientation. Due to the presence of triple insertions of Pm 5ƍ-UTR DNA fragments 
in strains tolerating high ampicillin concentrations, a colony PCR was performed prior to 
sequencing reactions to eliminate those constructs which contained more than a single 
Pm 5ƍ-UTR DNA region. My work benefitted from this observation at a later stage (see 
3.2.3). Looking at the sequence composition, 19 out of 22 carried a mutation that 
interrupted the extra ATG sequence found between the SD sequence and the actual start 
codon DNA sequence (Table 3.1A). Three out of 22 (n24, n35 and n59) increased the 
length of the SD by one nt and three by two nts (n44, n47 and n58). These are good 
indicators for improvement of translation because the SD-antiSD interaction is important 
during translation initiation. In the Pm 5ƍ-UTR sequence, the distance between the SD 
region and the ATG is relatively long (12 nts from the center of the SD sequence gGag to 
the ATG start codon) and with four nts in length the SD is relatively short. Osterman et al. 
[176] could show that for such big distances, a longer SD sequence is beneficial for 
efficient translation. 
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Characterization of Tr- and Tn-UTR DNA sequences at the accumulated transcript 
and protein level 
  
 After having identified the Tr- and Tn-UTR variants, different analyses were 
performed using the three strongest Tr-UTR variants together with the LV-2 control Pm 5ƍ-
UTR as well as four Tn-UTRs. The latter were chosen based on sequence composition 
(elongation of the SD region by one or two nts, change of the internal ATG or not, total 
number of mutations) to give a variation of sequence features. Effects of general 
sequence features within the 5ƍ-UTR affecting translation have been systematically 
investigated before [176]. To evaluate many criteria for good translation efficiency at the 
same time, computational tools such as the UTR designer [227] or the RBS calculator 
[218] can be applied. Data obtained from analyses with the RBS calculator are found in 
Paper II while data from the most important UTR variants studied in this thesis are shown 
below (Figure 3.4). Another way to study effects of 5ƍ-UTR variants on gene expression is 
to look at accumulated transcript and protein levels. For this purpose, the Tr- and Tn-UTR 
variants were transferred to pIB11, a monocistronic construct in which Pm  and its cognate 
5ƍ-UTR control expression of the bla gene alone. Strains harboring pIB11 constructs with 
Tr- and Tn-UTR variants were subjected to qPCR and protein analyses using an 
enzymatic assay.  
 
 
Figure 3.4: Analysis of the effect of selected 5ƍ-UTR variants on accumulated 
transcript levels and enzymatic activity as well as a theoretical analysis of the 
translation efficiency. Recombinant E. coli strains harboring pIB11 constructs with 
different UTR variants were induced with 0.5 mM m-toluate. Expression of bla was 
analyzed from samples taken 5 hours post induction using qPCR and a ȕ-lactamase 
assay. Results from one representative experiment are shown. The data were later 
confirmed by master student Jon A. Lorentzen. Below the bar diagram, the calculated 
translation efficiencies from two different softwares are shown. (unpublished data) 
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 Protein-to-transcript ratios of the Tr- and Tn-UTRs were in the range of 1.1-1.4 and 
1.2-2.6, respectively, under full induction (2 mM m-toluate) and slightly higher under 
partial induction (0.5 mM m-toluate). Data for some selected UTR DNA sequences are 
shown in Figure 3.4.  Interestingly, it could be demonstrated that mutations within the LV-
2 variant led to a significant improvement of protein production levels on top of increased 
accumulated transcript levels which was supported by the computational analysis. In 
contrast, the two important UTR variants identified in the study described in Paper II (SIII-
r31 and SII-n47) displayed more distinct characteristics with respect to transcription and 
translation stimulation. Overall, TIR values (RBS calculator) of the three Tr-UTRs were 
slightly (1.2-2.7 times) higher than for the wild-type Pm 5ƍ-UTR while the TIR values for 
the four Tn-UTRs were increased by a factor of 9.3-14.0. Based on these two criteria and 
a third analysis (change of position of the Tr- and Tn-UTRs in the artificial operon 
constructs (Paper II, Figure 2)), it was concluded that, most likely, Tn-UTRs mainly act on 
translation efficiency while Tr-UTR mainly, but not purely act on transcript accumulation.  
 
3.2.3 Development of a novel 5ƍ-UTR DNA sequence design to increase protein 
production levels 
 
 The 5ƍ-UTR variants that were identified using the two artificial operons were 
shown to display distinct characteristics with respect to influencing relative accumulated 
transcript amounts and enzyme activity. However, generally the overall improvement of ȕ-
lactamase production was lower than achieved by previously identified Pm 5ƍ-UTR 
variants (maximum 11-fold increase (n47; data not shown) vs. 20-fold increase at 
induction with 2 mM m-toluate; [25]). This could be explained by the fact that the 
mutations found in Tr- and Tn-UTRs mainly stimulate one of the processes instead of both 
at the same time. As a consequence, it was of great interest to combine mutations of 
different Tr-and Tn-UTRs to form a superior Pm 5ƍ-UTR variant in which both transcript 
accumulation and protein product formation were enhanced. Different potential design 
strategies were evaluated on how mutations that influence transcription or translation 
could be combined in a single 5ƍ-UTR DNA sequence.  
 The first idea was to merge mutations of a Tr-UTR variant with mutations from a 
Tn-UTR variant and generate a new 5ƍ-UTR with the same length as the original Pm 5ƍ-
UTR. But the UTR variants all differed in sequence composition. As an example, the 
mutations in the r31 Tr-UTR were only located in the stretch of DNA located upstream of 
 47
the SD sequence. However, the six mutations within the n47 Tn-UTR were spread across 
the entire mutated region and thereby overlapped with the mutated region of the r31 Tr-
UTR and the other Tr-UTRs. Therefore, it was not possible to merge the sequences or to 
piece together a Pm 5ƍ-UTR out of two segments, one from the Tr-UTR and another from 
the Tn-UTR.  
 The second idea was to combine the entire Tr-UTR with an entire Tn-UTR and 
separate the units with a spacer sequence. This second option had the advantage that 
effects caused by the mutations within a Tr-UTR variant would probably not interfere with 
ribosome binding and translation initiation due to the physical distance generated by the 
spacer sequence. At the same time, mutations around the ribosome binding site 
(contained within the Tn-UTR) would not affect transcription. The spacer design was 
based on the above described screening artifact where three Pm 5ƍ-UTR DNA sequences 
had been inserted simultaneously leading to high expression levels. At first, several 
parallel designs were tested; each of which contained three wild-type 5ƍ-UTR DNA 
sequences; one in the regular orientation, one in the inversed orientation and one 
additional in the regular orientation. However, the sequence of the inversed 5ƍ-UTR DNA 
sequence was modified in a way that the additional PciI and NdeI sites connecting the 
three sequences were removed and that one of several unique restriction sites was 
introduced in the center of this 5ƍ-UTR DNA sequence. This would ensure that the 5ƍ-DNA 
region and the 3ƍ-DNA region of the novel 5ƍ-UTR DNA region could be replaced using 
annealed oligonucleotides flanked by PciI plus enzyme X and enzyme X plus NdeI sites. 
Finally, one design was chosen with a SacI site in the center which gave rise to an 
ampicillin resistance level of 0.25 g L-1 at full induction (2 mM m-toluate). This pIB11-
derived construct was called pDUTR and the particular 5ƍ-UTR DNA region between the 
Pm promoter and the bla gene was termed dualUTR (Paper II).  
 
3.2.4 Generation of dualUTR DNA sequences that primarily enhance 
transcription, translation or a mixture of both 
 
 Based on the above described 5ƍ-UTR design, several mutations derived from Tr- 
and Tn-UTR DNA sequences were introduced in the 5ƍ-UTR DNA region and variants of 
this region were denoted as pairs of Tr- and Tn-UTR variants; e.g. wtwt for a dualUTR 
composed of two wild-type units. First, several Tr- and Tn-UTR DNA sequences were 
combined and the effect of the mutations was tested based on resulting ampicillin 
tolerance of the respective recombinant E. coli strains. Among the different combinations 
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tested, it was the mutations contained in Tr-UTR r31 which were able to exert the 
strongest increase in bla expression on top of the effect caused by mutations contained in 
the different Tn-UTR variants. Among the Tn-UTR variants, it was n47 which displayed 
the strongest stimulating ability on bla expression. In order to analyze the contributions of 
the different dualUTR sequences on bla expression more precisely, recombinant E. coli 
strains harboring wtwt, r31wt, wtn47 and r31n47 dualUTR variants were subjected to 
qPCR analysis and an enzymatic assay. One important observation was that the 
mutations in the three different dualUTR variants did lead to higher accumulated transcript 
levels compared to the wtwt combination. However, the protein product levels did not 
increase proportionally. Calculated ratios between relative protein and transcript amounts 
were 0.6 for r31wt, 4.1 for wtn47 and 3.6 for r31n47 (based on Paper II, Figure 4A).  
 These data support two hypotheses derived by Laila Berg ([237]; Figure 14). The 
first stated that, theoretically, there exist 5ƍ-UTR variants with maximized transcriptional 
stimulation ability but which are not optimal for translation. These 5ƍ-UTR variants would 
lead to stronger relative transcript accumulation than protein production with a protein-to-
transcript ratio below one. The r31wt dualUTR is an actual, practical example to support 
hypothesis 1 because it displays a protein-to-transcript ratio of ~0.6. This means that 
transcriptional features exerted by the Pm promoter region in combination with the 
mutations in the r31 Tr-region of the dualUTR are more dominant than translational 
features of the wt Tn-part which in turn could be interpreted by an uncoupling of the two 
processes. The second hypothesis states that there exist 5ƍ-UTR variants with maximized 
translation efficiency, but reduced transcript production rate. This would cause a protein-
to-transcript ratio well above one. Again, a 5ƍ-UTR variant, wtn47, could be generated 
which fulfils the criteria to prove hypothesis 2. Combining the r31 and n47 DNA regions 
into one 5ƍ-UTR causes a protein-to-transcript ratio of 3.6 which is just below the ratio 
caused by wtn47 (4.1). This indicates that transcriptional stimulation and translation 
efficiency are stimulated to a similar extent. However, an even lower ratio could be 
envisioned. This could be further exploited in the future by adjusting the Tr-DNA unit of the 
dualUTR to balance transcript accumulation even better with translation stimulation. 
According to the current understanding of the coupling of the transcription and translation 
machineries (section 1.3.4), the optimal ratio would be around one. This is why I hereby 
suggest a revised interpretation of the effects of the LV-2, namely that the mutations 
within this Pm 5ƍ-UTR variant lead to equally increased accumulated transcript and protein 
product levels. This can be supported by the theoretical findings (extended SD sequence 
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and higher TIR values which indicate a positive effect on translation initiation) as well as 
experimental data (protein-to-transcript ratio just above 1).  
 A parallel combinatorial engineering approach was performed in our research 
group [40]. In this study, it was not 5ƍ-UTR DNA sequences that act on transcription or 
translation, but variant elements of the XylS/Pm system acting on the two processes that 
were combined. In brief, the major finding of this story was that combination of variant 
elements that act on different steps of expression act in a stimulating manner. As an 
example, a xylS variant or a Pm variant which both stimulate transcription enhanced the 
positive effect of a 5ƍ-UTR variant which in turn mainly acts at the translational level. The 
total increase achieved by a combination of a xylS and a 5ƍ-UTR variant was around 50-
fold and the increase from a Pm and 5ƍ-UTR variant combined 25-fold (vs. 15 times 
increase compared to the wt by a 5ƍ-UTR variant alone). All three variant elements 
combined increased expression by a factor of 75.  
 
3.2.5 Application of a rational RBS design tool to change the Tn-UTR part of 
the dualUTR  
 
 Previous mutagenesis studies on the Pm 5ƍ-UTR demonstrated that there is a 
context dependency between the 5ƍ-UTR and the 5ƍ-proximal coding region. This means 
that 5ƍ-UTR variants identified in proximity to a certain gene would not exert the same 
effect on a second gene. The Tn-UTR variants tested in the dualUTR design (identified in 
proximity to the bla gene could enhance mCherry production by an impressive factor of 67 
(Paper II). This effect could have been predicted since the n47 variant and the 5ƍ-end of 
the mCherry gene form an RBS with a high TIR value compared to the wild-type (2,309 
vs. 12,766). Still, it is questionable whether the 5ƍ-UTR sequences in this study that were 
identified to give rise to high protein production levels of ȕ-lactamase (and mCherry) 
would work equally well for different genes. In order to avoid a new mutant library 
approach for every gene in order to find a suitable 5ƍ-UTR DNA sequence that would 
increase translation initiation in a predictive manner, an attempt was made to apply the 
RBS calculator again. The reason to apply this tool for the dualUTR constructs (now in the 
forward engineering mode) under the assumption that more reliable protein product levels 
could be achieved is based on the physical separation of the Tr- and Tn-UTR DNA 
elements. Since mutations in the Tn-part of the dualUTR are most likely too far away from 
the transcriptional start site to affect transcript accumulation, it was reasonable to assume 
that the Tn-part of the dualUTR could be optimized based on translation-enhancing 
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properties only without affecting transcript accumulation at the DNA level. As exemplified 
for ȕ-lactamase the use of three different designed Tn-UTR sequences (called dTn1-3 for 
designed Tn-dualUTR) resulted in the identification of at least one sequence which 
displayed increased protein production abilities equally well or better than the screened 
n47 Tn-UTR variant (Figure 3.5). This finding supports the hypothesis that a 5ƍ-UTR DNA 
sequence cannot be optimized based on translation-affecting properties only. Separation 
of the region of a 5ƍ-UTR DNA sequence which is part of the RBS from the ITS region, 
instead, opens up for the possibility to apply rational design tool to improve translation 
initiation.  
 
 
Figure 3.5: Comparative analysis of the effect of different 5ƍ-UTR DNA sequences on 
bla expression measured as ampicillin tolerance. Strains harboring pDUTR- or pIB11-
based plasmids with different dualUTR or Pm 5ƍ-UTR DNA sequences, respectively, were 
transferred to agar plates containing 0.1 mM m-toluate and increasing amounts of 
ampicillin. The highest concentration tolerated is plotted and error bars point to the next 
highest concentration that restricted growth. (derived from Paper II, Figure 6A).  
 
 In general, the data obtained in this study agree well with the current literature in 
the field of synthetic biology. For example, the issue of context dependency or junction 
interference is currently taken up. Different solutions to prevent unforeseen effects of 
combining promoter, RBS and genes are presented. Two additional articles describe the 
use of an endoRNase site [224] and a ribozyme encoding region [222] within the 5ƍ-UTR 
DNA region to cleave off the 5ƍ-part of the UTR in order to achieve a more predictable 
effect on translation initiation caused by a rationally designed RBS. Another study on the 
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other hand describes the benefits of applying a synthetic library approach to combine 
promoters and 5ƍ-UTR DNA sequences to achieve an optimal context between the 
promoter, the RBS and the gene and to be independent of predictions [228]. In general, 
the novel dualUTR described here could be applied for both strategies and it remains to 
be shown in the future which strategy gains more acceptance.  
 
 
3.3  Analysis of the effects of different plasmid backbones on 
gene expression  
  
 Heterologous gene expression can be directly affected by the choice of the 
promoter system (Paper I) and the 5ƍ-UTR (Paper II). In a broader perspective, e.g. at the 
systems level (expression vector); more parameters come into play which are able to 
exert an effect on protein production levels. These include the plasmid copy-number 
regulated by the origin of replication and associated plasmid control elements. In contrast 
to the first parameters, these would likely affect gene expression in a general, not gene-
dependent manner. 
 
3.3.1 Influence of plasmid stabilization elements on protein production  
 
 In previous studies the hok/sok system was used in pJB vectors to prevent plasmid 
loss under HCDC [20,68]. Another control region was used on mini-RK2 vectors, namely 
the par locus (Par) [76]. This locus is involved in postsegregational killing and plasmid 
multimer resolution. Both systems were able to stably maintain plasmids in cell 
populations in absence of selection. Besides the par locus, RK2 contains the OB1incC 
korB partitioning (Inc) region which is involved in spatial organization of the plasmid within 
a bacterial cell (see 1.2.1). However, it has not been shown before whether the use of 
such control regions would have a direct effect on heterologous protein production. 
Expression could be studied at the population level or at the level of individual cells using 
methods like flow cytometry. The outcome at the population level would then be the 
average sum of the production in each individual cell. Here, GFP expression was used to 
exemplify the influence of different elements contained in the plasmid backbone on protein 
production. Mini-RK2 plasmids were constructed based on pSB-M1g (Paper I) in which 
the Inc and Par loci (Figure 3.6A and B) were inserted downstream of the xylS gene. 
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GFP production was studied in E. coli MG16551 (Figure 3.6C-E). At the population level, 
both regions had a significant impact on GFP production increasing product levels by 
around 80% and 60% compared to when plasmids without control regions were used 
(Figure 3.6C).  
 
 
Figure 3.6: Influence of plasmid control regions on GFP expression profiles of 
recombinant E. coli cells harboring pSB-M1g. A Genetic organization of the OB1incC 
korB partitioning region of RK2 that is known to shift the location of mini-RK2 replicons 
towards the quarter- and mid-cell positions (derived from Verheust and Helinski [70]). B 
Organization of the par locus of RK2 containing the postsegregational killing system 
encoded by the parDE operon and the multimer resolution system encoded by parCBA. 
MRS multimer resolution site (derived from Sobecky et al. [75]) Both the OB1incC korB and 
the par locus were inserted into pSB-M1g (Paper I) downstream of the xylS gene and the 
resulting plasmids were called pSB-M1g Inc and pSB-M1g Par, respectively. C 
Recombinant E. coli MG1655 cells harboring pSB-M1g (Ø), pSB-M1g Inc (Inc) or pSB-
M1g Par (Par) were grown in LB medium according to the protocol described in Paper I 
and fluorescence values were determined 300 min post induction. After normalization, 
data were related to pSB-M1g. D During growth of E. coli MG1655 (pSB-M1g), samples 
were collected at different time points after induction and analyzed by flow cytometry. This 
time, a Becton Dickinson LSR flow cytometer and the Kaluza 1.1 software (courtesy of 
Physics Department, NTNU) were used. E In parallel, samples from E. coli MG1655 (pSB-
M1g Inc) and E. coli MG1655 (pSB-M1g Par) cultures were collected and distribution of 
cells collected 300 min after induction are presented.  
                                                 
1 This strain was used by our collaboration partner Judith Megerle at LMU Munich to study 
culture heterogeneity.  
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 Flow cytometry data were collected as well, following GFP production in individual 
cells over a period of five hours. This analysis revealed that onset of GFP production from 
mini-RK2 plasmids was generally slow. A significant population of cells that produced 
more GFP than the background level only formed one hour after induction (Figure 3.6D). 
Still, many cells remained uninduced as derived from the peak at low fluorescence values. 
Five hours post induction, most cells were induced. Distributions of cells harboring 
plasmids with the Inc and Par regions were strikingly similar to the distributions of cells 
harboring plasmids devoid any control region (Figure 3.6E). The only difference was that 
the major peak derived from induced cells was shifted towards higher fluorescence 
values. This is consistent with the data collected at the population level. 
 These results were somewhat surprising. It would have been possible that the 
presence of a multimer resolution system and a partitioning region would lead to a more 
homogenous distribution of plasmid between the cells in a population leading to a more 
homogenous expression. The data disprove this hypothesis. However, the presence of 
the Inc and Par regions was beneficial for the overall production level of GFP. This finding 
may be interpreted by assuming that a better distribution of plasmids within cells leads to 
a more favorable use of cellular resources (nts, amino acids, etc.). It is known that mRNA 
does not freely diffuse in a cell [238] due to a crowded cytoplasmic environment. 
Assumingly, transcripts stay in proximity to the plasmids. If plasmids are distributed at 
more locations within a cell, nutrients used for transcription and translation of 
heterologous genes can be used more efficiently [69]. This in turn might explain why more 
GFP can be produced from plasmid containing elements that lead to a more favorable 
positioning inside the cell.  
 
3.3.2 Influence of different origins of replication on protein production  
 
 A different way to change the distribution of plasmids within the cell is the use of 
different origins of replication leading to elevated plasmid copy-numbers. Therefore the 
effect of a pMB1-based plasmid backbone on GFP production was studied (Paper I and 
unpublished data). Overall, GFP production levels were increased, not only for plasmids 
containing the XylS/Pm system, but also XylS/Pm ML1-17, the LacI/PT7lac system, the 
LacI/Ptrc system and the AraC/PBAD system (Paper I, Figure 2). Increasing the copy-
number from four- seven (mini-RK2) to 15-20 (pMB1) led to 1.6- to 6.2-fold higher GFP 
levels depending on the promoter system. The relatively low increase for the LacI/PT7lac 
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system could be attributed to the accumulation of insoluble protein (Paper I, Figure 3) 
which was not detected by fluorescence measurements.  
 In a second analysis, populations of GFP producing cells were subjected to flow 
cytometry analysis. Surprisingly, the use of a pMB1-based backbone led to more 
homogenous populations compared to the use of RK2-based backbones as exemplified 
by GFP expression profiles of strains harboring the XylS/Pm system (Figure 3.7A). 
Already 20 min after induction, a single peak distinct from the uninduced peak was 
observed suggesting that all cells were induced and that these produced GFP. The peak 
migrated towards higher fluorescence values in agreement with fluorescence values at the 
population level (data not shown). Equally homogenous distributions were observed for 
the system with the Pm promoter variant Pm ML1-17 (Figure 3.7B). These data confirm 
that the use of a different plasmid backbone not only influences heterologous protein 
production in general, but also the homogeneity of a cell population. It can be assumed 
that this finding is based on how plasmids are distributed in a cell. However, a study 
visualizing plasmid distributions would be needed to confirm this hypothesis.  
 
3.3.3 Influence of different regulated promoter systems on protein 
production studied at the single-cell level 
 
 Another parameter influencing homogeneity of expression is the promoter type. 
The comparative analysis of different regulated promoter systems revealed that 
distributions of fluorescing cells differed quite significanty from one another. Populations of 
cells harboring plasmids with LacI/PT7lac were heterogeneous prior to induction and at later 
stages during expression (e.g. 5 hours post induction) (Figure 3.7C). The LacI/Ptrc system 
caused homogenous distributions throughout the time course (Figure 3.7D). However, 
production of GFP did not increase further from one hour post induction on. Finally, the 
AraC/PBAD system was characterized by a slower onset of GFP production, but 
distributions remained homogenous from one hour post induction on (Figure 3.7E). 
 A known issue associated with AraC/PBAD is the so-called all-or-nothing 
phenomenon. This is based on the finding that two populations of cells are observed in 
flow cytometry studies after induction with sub-saturating inducer concentrations [105]. In 
order to demonstrate this phenomenon also in the novel vector context and to compare 
the behavior of XylS/Pm ML1-17 to AraC/PBAD at lower inducer concentrations, a second 
experiment was conducted using 10-fold less inducer than in the full induction experiment 
(Figure 3.7F and G). The analysis revealed that GFP expression driven from the Pm 
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ML1-17 promoter variant led to formation of homogenous cell populations. Meanwhile, a 
significant portion of cells harboring constructs in which GFP production was regulated by 
the PBAD promoter displayed a behavior similar to uninduced cells. 
 
 
 
Figure 3.7: Distribution of cells producing GFPmut3. Recombinant cells were grown 
and expression was analyzed according to the protocol described in Paper I. A  E. 
coli ER2566 pSB-M2g B E. coli ER2566 pSB-M2g-1-17 C E. coli ER2566 pSB-E2g D E. 
coli ER2566 pSB-T2g E E. coli DH10B pSB-B2g. In addition to studies at full induction, 
gfpmut3 expression was also induced with a 10-fold lower inducer concentration for some 
selected strains: F E. coli DH10B pSB-M2g-1-17 induced with  0.2 mM m-toluate G E. coli 
DH10B pSB-B2g induced with 0.0015 % L-arabinose (derived from Paper I and 
unpublished data).  
 
These findings can be related to inducer uptake. L-arabinose, the inducer of the AraC/PBAD 
system, namely, undergoes active transport by one high-capacity, low-affinity L-arabinose 
transporter and one high-affinity transporter (see 1.2.2). By making regulation of the 
production of the L-arabinose transporters independent of the inducer, homogenous cell 
populations could be achieved [102]. The XylS/Pm system whose inducer molecules enter 
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the cell by passive diffusion did not need to be modified (other than the replicon on the 
plasmid backbone) in order to achieve homogenous populations. This represents a great 
advantage of XylS/Pm over regulated promoter systems that are induced by molecules 
requiring an uptake system (e.g. AraC/PBAD).   
 
3.4  Analysis of the effects of different growth conditions on 
protein production 
  
 The focus of this PhD project as described up to this point has been on the genetic 
elements of expression cassettes only. However, it is well known that the surrounding 
environment of an expression vector (e.g. cell cytoplasm and culture medium) affects 
recombinant gene expression. Under laboratory scale experiments, a range of parameters 
can be tested with respect to the yield of a heterologous protein product. A selection was 
tested during this PhD project using XylS/Pm to express genes coding for two capsid 
proteins of the Norwegian Salmonid Alphavirus (NSAV) called E1 and E2. The results are 
presented in the following two subchapters. 
   
3.4.1 Production of Norwegian Salmonid alphavirus E1 and E2 capsid 
proteins in E. coli 
 
 Analyses so far in addition to several previous studies revealed that the XylS/Pm 
system possesses beneficial traits for various recombinant expression purposes, amongst 
them the ability to produce industrial levels of heterologous proteins in a fermentor [20,68]. 
These traits were again put to the test by trying to produce medically relevant proteins. In 
a KMB2 project (which this PhD project was indirectly associated with), Pharmaq, one of 
the four industry partners, supplied genes encoding NSAV E1 and E2 to be expressed 
within the project (Paper III). The goal was to produce the target proteins as antigens to 
make it possible to derive antibodies against them for use as vaccines later on. In order to 
produce antigens, a simple bacterial host such as E. coli can be used. A literature study 
and bioinformatics analysis suggested that these proteins were likely to be difficult to 
produce due to their origin (fish virus), the predicted presence of transmembrane helices 
and disulfide bonds. This led to a rational choice of an expression system. In Paper I it 
                                                 
2 A Combinatorial Mutagenesis Approach to Improve Microbial Expression Systems (Norwegian 
Research Council project; Project nr: 182672/I40) 
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could be shown that the XylS/Pm system in combination with a replicon leading to an 
intermediate plasmid number could yield intermediate, yet detectable protein production 
levels, a good ratio between soluble and insoluble protein on top of the ability to fine-tune 
expression levels without the need of making new genetic constructs, for example by 
varying the inducer concentration. It was decided to use the system in its wild-type form 
as a basis to have an intermediate starting point with respect to production capacity. 
Using a too strong promoter for toxic proteins as an example could stress the cells which 
increases the probability to accumulate IBs. As a plasmid backbone, mini-RK2 replicons 
containing trfA variant cop271C and the hok/sok suicide system were chosen based on 
the pJB series of plasmids. Starting broad, full-length genes encoding E1 and E2 as well 
as truncated versions devoid of the transmembrane and hydrophobic interaction domains 
were cloned into the pJB vectors. This protein engineering strategy was pursued to 
increase chances to achieve production of soluble target proteins. It could be justified with 
the fact that potential epitopes would not be located in the parts of the proteins that are 
buried inside the membrane or inside regions that form interaction surfaces with 
associated proteins. Another choice that was made early on was the use FPs. N-terminal 
FPs comprised CSP and OmpA, two signal peptides which accomplish translocation of 
the target proteins to the periplasm. Both were previously shown to facilitate dramatic 
improvement of protein production besides being properly cleaved off [20,68]. Also, 
combinations of the Pm 5ƍ-UTR DNA region and the coding regions for the CSP and 
OmpA signal peptides formed RBS with TIRs of 3,621 and 5,190, respectively, which are 
well in the range of TIRs described earlier. Therefore, no particular 5ƍ-UTR modification 
strategy was applied. C-terminal FPs included the c-myc and His6 tags for detection and 
affinity purification. A schematic representation of the arrangements of the genetic 
elements that were coupled together during this study can be found here: Paper III, Figure 
1. Further decisions regarding the choice of E. coli strains (RV308 and BL21-
CodonPlus(DE3)-RIPL) and growth medium (Hi+YE) can also be found in this article.  
 
3.4.2 Recombinant production of the NSAV E1 and E2 capsid proteins in 
small-scale under influence of different growth conditions 
 
 A common understanding among researchers working in the field of recombinant 
expression is that it is useful to approach laboratory-scale experiments from a broad 
parameter perspective due to many unforeseen effects in the upstream process. This is 
the reason why the influence of different parameters on production of the NSAV E1 and 
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E2 proteins was tested. These included protein engineering, choice of genetic context 
(see 3.4.1) and physiological conditions. The primary focus was to produce as much 
soluble virus protein as possible. Recombinant E. coli strains producing different variants 
of the E1 and E2 proteins with or without N-terminally fused signal peptides were grown at 
30 °C and expression was induced with 0.5 mM m-toluate. After the first round of 
experiments, it could be concluded that presence of the additional tRNAs produced by the 
E. coli BL21-CodonPlus(DE3)-RIPL strain did not improve soluble E1 and E2 production. 
Due to better growth characteristics E. coli RV308 was selected for use in these 
experiments (data not shown).  
 Furthermore, it could be shown that production of the virus proteins affected 
bacterial growth which is why it was decided to induce expression from XylS/Pm in the 
middle of the logarithmic growth phase (corresponding to OD600 = 8-10 in Hi+YE 
medium) (Figure 3.8A-D). Especially the use of a signal sequence led to reduction of 
growth after induction an effect which became most evident for the E2 protein in its full-
length form (Figure 3.8B). 
 Growth of strains producing the truncated form of E1 (E1ǻIDTM) was only slightly 
impaired in the first 2 hours after induction. However, production of these proteins 
appeared to be host-toxic from then on, a conclusion drawn from the significant reduction 
of OD600 from ~20 down to ~15 (Figure 3.8C). Growth of recombinant E. coli RV308 
strains producing E2ǻIDTM was only marginally impaired for the ones in which the protein 
was fused to CSP (Figure 3.8D). In the next step, periplasmic extracts were prepared and 
a Western blot analysis was performed to study the fraction of soluble and insoluble 
recombinant protein (Figure 3.8E and F). Comparison of the different strategies 
performed revealed that truncation had the most predominant effect on increasing both 
the soluble and insoluble fraction while fusion to signal sequences had a minor 
contribution. Truncation also rendered production of the viral proteins less toxic to the 
cells which could be shown for E1 to a certain extent and to a greater extent for E2.  
 From this point on, strategies to improve the soluble fraction were pursued. The 
first was temperature reduction to 16 °C after induction, the next decrease of the inducer 
concentration and the third, use of the Chaperone Plasmid Set from the TaKaRa. Western 
blot analysis revealed that the functionality of XylS/Pm was maintained at low 
temperatures such that fine-tuning of the inducer concentration (here use of 0.1 mM) 
increased the soluble fraction compared to when 0.5 mM was used. The use of 
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chaperones, however, was not suitable to significantly increase the soluble protein fraction 
(data not shown).  
 
 
Figure 3.8: Study of Norwegian Salmonid Alphavirus E1 and E2 protein production 
regulated by the XylS/Pm system. Growth curves of recombinant E. coli RV308 strains 
producing different variants of E1 (A: full-length proteins and B: truncated proteins) and 
E2 (C: full-length proteins and D: truncated proteins). pJB658 is a mini-RK2-based 
plasmid without a gene of interest and confers AmpR. For details see Paper III. Cell 
lysates were subjected to Western blot analysis. E Lysates obtained from E1-producing 
strains grown at 30 °C (0.5 mM induction) F Lysates obtained from strains grown at 16 °C; 
induction of OmpA-E1ǻIDTM production with decreasing m-toluate concentrations. G 
Same as E, but with E2-producing strains. H Same as F, but with E2-producing strains. 
(Paper III and unpublished data).  
 
 In this study, several classic approaches to address solubility were assessed like 
reduction of growth temperature and inducer concentration as well as use of chaperons to 
aid the folding process. Further strategies could have been applied like the use of 
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solubility-enhancing FPs (e.g. NusA or MBP) [239] or the addition of additives like L-
arginine, glycine betaine or mannitol) [240]. However, since early refolding attempts of the 
insoluble aggregates followed by Ni-NTA affinity chromatography were successful (Paper 
III, Figure 3), alternative strategies for increasing the soluble protein fraction were not 
pursued.  
 
3.5   Investigations on how the bacterial host affects expression 
of heterologous genes that are under control of XylS/Pm 
 
 E. coli is the predominant bacterium used in recombinant expression [18]. 
However, limitations of using this host can be seen compared to other bacteria with 
respect to safety (production of endotoxin) and production of insoluble aggregates (see 
Paper I and Paper III). Therefore, the use of alternative bacteria was considered. In the 
following two subchapters, some unpublished findings will be described involving the use 
of P. putida and cold-adapted members of the genus Pseudomonas. These strains were 
used in very preliminary experiments to test their potential to be used as alternative 
expression hosts and the the majority of the results have not been published, yet.  
 
3.5.1 Exploring P. putida as a host to produce recombinant proteins from 
XylS/Pm 
 
 P. putida is the bacterium from which the pWWO plasmid was isolated. This 
plasmid is the source of the xylS gene and the Pm promoter meaning that the XylS/Pm 
promoter system is able to function for recombinant gene expression purposes in this 
bacterium. Moreover, mini-RK2 plasmids are known to be maintained in this organism 
[65]. Due to these two prerequisites, it was decided to directly transfer some of the newly 
constructed vectors into P. putida KT2440, a strain cured for the pWWO plasmid. In the 
line of systematic studies performed during this PhD project, production of a target protein 
was directly compared between E. coli and P. putida using the exact same plasmids, 
growth media, growth temperatures and inducer concentrations. The constructs that were 
chosen contained the gene coding for the red-fluorescent mCherry protein [241] (gene 
coding region optimized for expression in E. coli) under control of XylS/Pm connected to 
different Pm 5ƍ-UTR DNA variants (Figure 3.9). The first important observation was that in 
E. coli the relative improvement of mCherry production achieved by (dual)UTR variants 
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compared to the wtwt dualUTR was lower than the relative improvement of ȕ-lactamase 
production achieved by different (dual)UTR variants (Figure 3.9A).   
  
 
Figure 3.9: Comparative analysis of mCherry production in E. coli and P. putida 
under influence of different 5ƍ-UTR DNA sequences. Recombinant E. coli DH5Į (A) 
and P. putida KT2440 (B) strains producing mCherry from XylS/Pm were grown in 96-well 
plates at 30 °C and induction was accomplished by addition of 1 mM m-toluate after which 
growth was continued (5 h). Fluorescence values (in arbitrary units) were determined, 
normalized against OD600 and related to data obtained for strains harboring plasmids with 
the wtwt dualUTR (arbitrarily set to 1.0). Data represent averages and standard deviations 
from three biological replicas. U11 and U38 are the best 5ƍ-UTR variants that have been 
identified by Rahmi Lale and Friederike Zwick when screening the same 5ƍ-UTR library for 
high mCherry expression in E. coli or P. putida, respectively.3 'dTn' variants (length of the 
Tn-UTR part of the dualUTR) and 'dIB' variants (Pm 5ƍ-UTR length) represent 5ƍ-UTR DNA 
regions that were specifically designed by the RBS calculator to give maximal TIRs for 
mCherry. The sequences are the same for E. coli and P. putida due to the shared anti-SD 
sequence found in the 16S rRNA of these two bacteria. Production of mCherry under 
influence of different dualUTR variants was also compared between the two bacteria 
grown in shake flasks. C Relative normalized fluorescence values obtained from E. coli 
cultures. D SDS-PAGE analysis of the soluble fraction of the total protein obtained from E. 
coli. E Relative normalized fluorescence values obtained from P. putida cultures. F SDS-
PAGE analysis of the soluble fraction of the total protein obtained from P. putida. 
Molecular weight of mCherry: 28.8 kDa; St: Precision Plus DualColor (BioRad). (Paper II 
and unpublished data) 
                                                 
3 Part of the project: ‘Development of versatile bacterial expression systems for use in recombinant protein    
  production, metabolic engineering, and systems biology’ 
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 The relative improvement was even less in P. putida (Figure 3.9B). As an 
example, the best UTR DNA sequence (dualUTR r31n47) stimulated mCherry production 
about 45 times in E. coli and only about 8 times in P. putida.  
 The next important finding was that the synergistic effect of combining an improved 
Tr-UTR DNA sequence with an improved Tn-UTR DNA sequence in the dualUTR context 
was also true for mCherry in both bacteria (Figure 3.9A-C and E).  
 Third, the use of a dualUTR variant gave rise to higher relative mCherry 
fluorescence compared to a Pm 5ƍ-UTR DNA variant. This effect was more evident for E. 
coli than for P. putida. 
 The fourth finding was that application of the RBS calculator to design novel Tn-
UTR or Pm 5ƍ-UTR DNA sequences generally led to similar fluorescence values than 
caused by Tn-UTR or Pm 5ƍ-UTR DNA sequences identified by screening. An exception 
was that the dIB4-6 UTR variants tested in E. coli led to less improvement of mCherry 
production than caused by UTR variant U11. This supports the hypothesis from above 
(3.2.1) that a short UTR DNA sequence such as the Pm 5ƍ-UTR cannot be optimized for 
high expression based on improving translation initiation only. When comparing total 
soluble production of mCherry between the two bacteria (Figure 3.9D and F), it became 
evident that production in P. putida was clearly higher than in E. coli. This observation can 
be interpreted with a generally higher efficiency of the XylS/Pm system in this host. Since 
this system originates from P. putida, one can assume that the action of the host factors 
(e.g. ı-factors, RNA polymerase etc.) leads to a more efficient transcription from Pm. This 
could explain the finding that the r31wt dualUTR DNA sequence does not increase 
mCherry production compared to the wtwt sequence. Just like in Zwick's study [40], there 
is a limit in how far protein production can be stimulated by just enhancing transcription. In 
her study, a XylS variant in combination with a Pm promoter variant (both acting on 
transcription) could not improve bla expression further than achieved by the variants 
alone. In this case, when we assume that the Pm promoter is stronger in P. putida than in 
E. coli, an additional effect on transcription exerted by the r31 UTR variant would not be 
evident on the protein product level. In fact, r31 even decreased mCherry production 
compared to the wt Tr-UTR.   
 To summarize this analysis it can be concluded that P. putida KT2440 is a well-
suited host for expression of mCherry. The mini-RK2 plasmids containing XylS/Pm can be 
used as expression system in this host making it possible to explore the influence of 
different genetic elements even further. Also, the XylS/Pm system appears to be stronger 
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in this host compared to E. coli. The use of constructs with artificial dualUTR variants was 
proven to be useful for this host as well. For example, it could be demonstrated that it is 
possible to adjust the Tn-UTR part of the dualUTR to a certain coding region. Generally, 
genetic manipulation is simple and standard media such us LB are proven to be suitable. 
Based on this and the findings described above it can be recommended to test expression 
of other genes in this host as well.  
 
3.5.2  Use of cold-adapted Pseudomonas hosts for recombinant protein 
production  
 
 Besides relying on existing expression platforms, efforts are made on finding novel 
hosts for recombinant protein production. Sources for novel hosts can be environments 
with extreme temperatures for example. Especially organisms adapted to cold 
environments are often explored for their potential to be used as expression hosts. These 
might circumvent common problems associated with mesophilic hosts like E. coli and P. 
putida such that growth of the cold-adapted bacteria would actually be promoted at low 
temperatures and that thermally labile proteins or proteins prone to aggregation and 
protease degradation might be functionally expressed [242]. In the MARZymes project4 
which was ongoing during the period of this PhD project, marine arctic microorganisms 
isolated from environmental samples and proteins selected based on data mining of 
metagenomic libraries were sent to NTNU for expression analyses. After careful selection, 
four strains that were shown to be cold-adapted members of the genus Pseudomonas 
(based on 16S rRNA analysis) and 11 genes encoding enzymes with putative functions as 
proteases, carbohydrases and nucleases were handed over to me. These proteins were 
mainly produced as insoluble aggregates in E. coli (Rahmi Lale/ UiT, personal 
communication). The rationale was to construct vectors for expression of these 11 genes 
based on XylS/Pm and the mini-RK2 replicon and to explore whether the target proteins 
could be produced in their soluble form using the four cold-adapted Pseudomonas hosts.  
 To achieve this goal two methods were used:  
 (1) One-step SLIC (1.2.4) to fuse the open reading frame to His6 tag coding 
regions to the 5ƍ- or the 3ƍ- end of the gene and transfer of these gene fusions to the 
plasmid backbone in one step.  
                                                 
4 Molecules for the future - Novel enzyme activities from environmental libraries, UiT, NTNU, Umeå 
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 (2) Colony filtration (CoFi) blot, a medium-scale method to evaluate production of 
the soluble fraction of the different fusion proteins in different host strains under different 
growth conditions simultaneously (Figure 3.10A).  
 
Application of sequence- and ligase- independent cloning (SLIC) 
 One-step SLIC was carried out using three DNA fragments. The first fragment 
comprised the vector backbone. Basically, the backbone covered the region between the 
NdeI and BamHI sites of pSB-M1x (Paper I) where the trfA gene was replaced with the 
trfA cop271C variant (made by Hanne Jørgensen). The His6 coding region was generated 
by annealing two overlapping oligonucleotides which also contained complementary 
regions towards the vector backbone. The third fragment consisted of a PCR product 
covering the coding region of the target protein, a complementary region towards the 
backbone at one end and a complementary region to the His6 coding region at the other 
end. The SLIC reaction was performed according to the protocol described by Jeong et al. 
[129] and the plasmids were transferred to E. coli. After confirming the correct insertion of 
the coding region by sequencing, the correct constructs were transferred to P. putida 
KT2440 (control strain) by electroporation and to the four cold-adapted Pseudomonas 
strains L11, H12, H26 and H32 by conjugation (the latter step performed by Rahmi Lale). 
Out of 22 possible variants (11 target genes, two positions of His6 coding regions), 13 
were successfully transferred to P. putida KT2440, 13 to L11, 10 to H12, 11 to H26 and 11 
to H32.  
 
Establishment and application of the Colony filtration blot method 
 In parallel to making the genetic constructs, the CoFi method [243,244] was tested. 
CoFi works as follows: Recombinant strains producing certain proteins which can be 
detected using specific antibodies are grown on agar plates. When colonies have formed, 
they are lifted up from the agar plate using a Durapore® membrane (Millipore) which is in 
turn placed on top of a new agar plate containing an appropriate inducer, colony side 
facing up. This new plate is then incubated at the desired induction temperature for a 
certain time (e.g. 30 °C, 5 hours for E. coli). Next, a filter sandwich is assembled 
according to Figure 3.10A and covered in lysis buffer. Upon cell lysis, the soluble proteins 
diffuse through the Durapore® membrane onto the nitrocellulose membrane. This 
nitrocellulose membrane is then subjected to immunoblotting to visualize the proteins. 
With this method, one can screen libraries of small and intermediate size (several 
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thousand clones) for soluble protein expression. The great advantages are that this 
method is independent of reporter protein FPs which might interfere with the structure of 
the target protein and that the throughput is higher compared to approaches in 96-well 
format using filtration or centrifugation to separate the soluble and insoluble protein 
fractions [245].  
 This method was first tested using two E. coli RV308 strains; one expressing hGH 
(Paper I) which was predominantly expressed in its soluble form and PelB-IFN-Į2B [74] 
which was only detectable in the insoluble protein fraction (Figure 3.10B). CoFi results 
were consistent with previous findings judged from the strong signal for hGH and the 
weak signal for PelB-IFN-Į2B.  
 Next, the CoFi method was applied to evaluate the cold-adapted Pseudomonas 
strains as novel expression hosts based on their ability to express soluble target proteins 
(Figure 3.10C-F). P. putida KT2440, Pseudomonas L11, H12, H26 and H32 were grown 
at 5 °C, 10 °C and 20 °C during the induction period to compare different temperatures. 
This comparative analysis revealed that signals derived from strains subjected to 10 °C 
were generally stronger than signals obtained from strains subjected to 5 °C or 20 °C. 
Moreover, signal intensity was higher for the cold-adapted strains than for P. putida. 
Among the cold-adapted strains, it was H32 and H26 that gave rise to the most intense 
signals. These results looked very promising because they indicated that the cold-adapted 
Pseudomonas strains were able to produce the target proteins in their soluble form. 
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Figure 3.10: Application of the Colony filtration blot (CoFi) method to evaluate cold-
adapted Pseudomonas strains expressing genes originating from a metagenomic 
library under different growth conditions. A Schematic representation of the CoFi filter 
sandwich. First, a Whatman filter is placed into a petri dish followed by a nitrocellulose 
membrane. These two layers are soaked in lysis buffer containing lysozyme amongst 
others. A Durapore® membrane with bacterial colonies attached is then placed on top of 
the nitrocellulose membrane. Cells are lyzed enzymatically and by repeated freeze-and-
thaw cycles. The soluble protein fraction diffuses through the Durapore® membrane and 
is blotted onto the nitrocellulose membrane. After disassembling the filter sandwich, 
proteins can be detected via specific antibodies [244]. B Results from a CoFi trial 
experiment. E. coli RV308 cells were transformed with pSB-M2h harboring the gene 
encoding human growth hormone which was mainly expressed in its soluble form (Paper 
I) or pVK1 harboring the gene coding for IFN-Į2b with an N-terminal PelB FP and C-
terminal c-myc and His6 tags [74]. The latter was mainly expressed in its insoluble form. 
Cell suspensions were spread on agar plates, colonies were lifted up with a Durapore® 
membrane which was transferred to new agar plates containing 1 mM m-toluate and 
grown for 5h at 30 °C. C-E Four different cold-adapted Pseudomonas strains (L11, H12, 
H26 and H32) in addition to P. putida KT2440 were transformed with plasmids containing 
XylS/Pm to control expression of interesting genes from a metagenomic library encoding 
different proteins (No 1,3,4,7,8 (version 1 and 2), 9,12,13 (version 1 and 2) and 32) with 
N-terminal (N) or C-terminal (C) His6 tags. x denotes an empty position. Strains were 
generally grown at 20 °C, but growth was continued at different temperatures after 
induction (1 mM m-toluate). Proteins were detected using the HisProbeTM-HRP 
(ThermoScientific) and the Pierce ECL Western blot substrate. F Arrangement of the 
recombinant strains on agar plates used in C-E. G Western blot results of recombinant 
H32 strains expressing different proteins from the metagenomic library. Strains were 
grown in LB medium at 20 °C until OD600 = 0.4-0.5. Then 1 mM m-toluate was added and 
growth was continued at 10 °C over night. A Western blot was performed and the His-
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tagged proteins were detected using HisProbe TM-HRP (1:2,000) The order is: L (Precision 
Plus Dual Color, BioRad);1 - negative control (H32 without any plasmid); 2 - N12; 3 - C7; 
4 - C8; 5 - C9; 6 - C12; 7 - C13.1; 8 - C13.2; 9 - C32 Arrows point to 43 and 36 kDa, the 
expected molecular weights of proteins C13.1 plus C32 and C13.2, respectively.  
  
   
 To confirm the CoFi results, some strains were selected for experiments in shake-
flasks (Figure 3.10G). Western blot analysis revealed that expression of the target 
proteins was generally close to the detection limit. Especially when analyzing the soluble 
protein fraction, it became evident that the CoFi results and the Western blot result did not 
match well. The protein no 7 with a C-terminal His-tag for example gave rise to the 
strongest signal using the CoFi procedure (Figure 3.10D). In contrast, no signal was 
detected using Western blot analysis from samples taken after growth in shake flasks 
(Lane 3 in Figure 3.10G). Only the two variants of protein No 13 gave rise to a weak 
signal (Lanes 7 and 8 in Figure 3.10G). Inspection of the Western blot membrane derived 
from samples taken from the insoluble protein fraction revealed that several more proteins 
could be detected. However, others were not detected at all (data not shown). These data 
led to the conclusion that the cold-adapted Pseudomonas strains have a certain potential 
to be used as expression hosts for heterologous proteins. However, more work would be 
needed to find more suitable growth conditions (media, shaking, etc.) to be able to 
transfer results obtained from agar plates to liquid cultures. And although the CoFi method 
is not 100% reliable [243], it still represents a simple, easy-to-adopt and relatively fast 
method to select among several conditions and strains simultaneously. The more detailed 
characterization of the strains of course is left to experiments in liquid cultures.  
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4 Concluding remarks  
 
 The work presented in this thesis addressed different issues related to bacterial 
recombinant expression with special focus on increasing recombinant protein production. 
The work mainly dealt with genetic and physiological parameters like regulated promoters 
(such as XylS/Pm), variants of the Pm 5ƍ-untranslated region and bacterial host strains (E. 
coli and others) and did not focus on the coding region of the target protein.  
 One important conclusion is that the systematic comparison of the performance of 
different regulated promoters in recombinant protein production was necessary to unravel 
direct effects of these on different steps involved in gene expression. Despite theoretical 
knowledge about the features of certain regulated promoters, it would not have been 
possible before to truly evaluate the use of the chosen promoter systems for certain 
expression purposes, especially XylS/Pm and AraC/PBAD which had not been included in 
systematic comparisons before. This work also confirms the advantage of starting with a 
small portfolio of bacterial expression platforms including different promoters to identify 
bottlenecks in expression.  
 In addition, several strategies are presented how to deal with certain bottlenecks. 
For once, it could be demonstrated that adjustment of the Pm 5ƍ-UTR DNA region might 
help to prevent that limitations associated with the initiation phase of transcription and 
translation occur. An especially important contribution was the development of the 
versatile artificial dualUTR tool which makes it possible to increase protein production in a 
less gene-dependent, less laborious and more rational manner compared to previous 
tools. For the future, it would be of great interest to adjust the artificial dualUTR tool to 
other regulated promoter systems to design an even more flexible set of vectors for early 
stages in a protein production process. 
 On top of that, more general strategies to improve protein production are 
presented which include the incorporation of plasmid stabilization elements in the 
expression vectors and the use of several bacterial hosts. Further adjustments regarding 
the Pm promoter core region, the regulator protein XylS or the 5ƍ-end of the coding region 
were already performed by my former colleagues and it would be of great value to 
combine the genetic engineering strategies of XylS/Pm presented here with strategies 
presented in related work in the future. 
 Although incorporation of the different presented parameters would mean that a 
range of strains needs to be constructed and tested, use of modern cloning and screening 
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technologies can facilitate higher throughput than achieved by constructing and testing 
strains one by one.  
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Abstract
Background: Production of recombinant proteins in bacteria for academic and commercial purposes is a well
established field; however the outcomes of process developments for specific proteins are still often unpredictable.
One reason is the limited understanding of the performance of expression cassettes relative to each other due to
different genetic contexts. Here we report the results of a systematic study aiming at exclusively comparing
commonly used regulator/promoter systems by standardizing the designs of the replicon backbones.
Results: The vectors used in this study are based on either the RK2- or the pMB1- origin of replication and contain
the regulator/promoter regions of XylS/Pm (wild-type), XylS/Pm ML1-17 (a Pm variant), LacI/PT7lac, LacI/Ptrc and AraC/
PBAD to control expression of different proteins with various origins. Generally and not unexpected high expression
levels correlate with high replicon copy number and the LacI/PT7lac system generates more transcript than all the
four other cassettes. However, this transcriptional feature does not always lead to a correspondingly more efficient
protein production, particularly if protein functionality is considered. In most cases the XylS/Pm ML1-17 and LacI/
PT7lac systems gave rise to the highest amounts of functional protein production, and the XylS/Pm ML1-17 is the
most flexible in the sense that it does not require any specific features of the host. The AraC/PBAD system is very
good with respect to tightness, and a commonly used bioinformatics prediction tool (RBS calculator) suggested
that it has the most translation-efficient UTR. Expression was also studied by flow cytometry in individual cells, and
the results indicate that cell to cell heterogeneity is very relevant for understanding protein production at the
population level.
Conclusions: The choice of expression system needs to be evaluated for each specific case, but we believe that
the standardized vectors developed for this study can be used to more easily identify the nature of case-specific
bottlenecks. By then taking into account the relevant characteristics of each expression cassette it will be easier to
make the best choice with respect to the goal of achieving high levels of protein expression in functional or non-
functional form.
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Background
Parameters affecting recombinant protein expression in
Escherichia coli have been studied extensively and nu-
merous methods aiming at improving protein yields have
been reported, usually involving genetic manipulations
and/or production process optimization [1-4]. However,
in spite of the large number of potentially useful ap-
proaches available there is still no guarantee that a satis-
factory result will be obtained in each specific case, and
trial and error is therefore currently an integrated part
of development of new protein production processes.
The work involved in this can become very laborious
since many parameters such as choice of strains, vector
construct designs, growth media and cultivation condi-
tions can potentially have a big and unpredictable effect
on the process. Steadily more promoter systems for reg-
ulated protein expression in E. coli ([1] and references
therein, [2-6]) are being developed, increasing the com-
plexity. The studies of those novel expression systems were
commonly based on experiments involving vectors with
different backbones [2,4,7,8]; typically commercially avail-
able and commonly used vectors from the pET [9], pTrc
[10] or pBAD [11] series. More theoretical approaches have
also been used [6,12]. However, expression is influenced by
many parameters even within vectors, like the presence or
absence of sequences of the 50 coding region encoding N-
terminal fusion partners (His6 tag [13], N-terminal signal
peptides [14], and others), different origins of replication
[15-17], different terminators [18] or selection markers.
Penicillins for example are very frequently used for se-
lection in spite of their known rapid degradation due to se-
creted β-lactamase [19]. A first step towards a more
systematic, backbone-independent approach is described
in a study performed by Tegel et al. [20] in which ex-
pression from three different IPTG-inducible promoters
(PT7lac, Ptrc, Plac) is compared. These are all based on the
negative regulator LacI, while positively regulated pro-
moters such as PBAD and Pm have not been used in such
comparative studies. The regulators of these two pro-
moters (AraC and XylS, respectively) are both members of
the same family of transcriptional activators [21]. The
AraC/PBAD system is quite extensively used and its charac-
teristics have been reviewed [1]. The XylS/Pm system was
included because it has several beneficial traits for protein
expression in general (reviewed by Brautaset et al. [21]),
and in combination with RK2 minimal replicons it has
been demonstrated to be capable of expressing proteins at
industrial levels in high cell density cultivations [14,22],
We have used this system extensively in our laboratory as
a model for studies of recombinant gene expression. Par-
ticular advantages of this system are that the levels of ex-
pression can be fine-tuned by various means [23-25], that
it is not host-dependent in contrast to most other systems
and that the inducer is cheap. Furthermore, expression
from the native system could be greatly improved by gen-
erating variants of the regulator protein XylS [26], the
DNA region corresponding to the Pm promoter region
[27] as well as the region corresponding to the Pm 50-
untranslated region (50-UTR) [28].
In this report we describe a systematic comparison of
both positively and negatively regulated expression sys-
tems. Being aware of the influence of the 50 end of the
coding region on expression [29,30], we intentionally
chose to use model genes with native 50 ends as opposed
to commonly used regions encoding N-terminal detec-
tion tags or solubility-enhancing fusion partners. The ex-
pression analyses were carried out at both the transcript
and the protein level (activity assays and total protein), and
we also included a flow cytometry based analysis of expres-
sion in individual cells. All comparisons were performed
using identical vector backbones, a procedure we believe
can be used generally as a diagnostic tool to identify bottle-
necks in recombinant protein production processes.
Results and discussion
Construction of a set of plasmids specifically designed for
comparative studies of commonly used expression
systems in E. coli
To reduce potential effects on expression unrelated to
the features of the regulator/promoter systems them-
selves all replicons used for comparisons were designed
in such a way that the backbones were identical and the
expression cassettes were in all cases integrated at the
same location (Figure 1 and Table 1). The selected sys-
tems include XylS/Pm (the native system; denoted in the
figures as M); the high level expression variant Pm ML1-
17 (abbreviated by M-1-17) [27]; LacI/PT7lac originating
from the pET vector series (Novagen; denoted as E);
the LacI/Ptrc system from the pTRC series of vectors
(Pharmacia; denoted as T); and finally the AraC/PBAD
system from the pBAD series of vectors (Invitrogen,
abbreviated by B). Further details related to transcrip-
tional start sites and 50-UTR regions are described in the
Methods section.
It is well known that gene dosage and expression levels
often correlate, at least to some extent. In order to in-
vestigate any potential gene-specific effects related to
this the cassettes were integrated into a mini-RK2 based
replicon (pSB-M1b, 5–7 copies per cell [33]), and the
pMB1 replicon (15–20 copies per cell [19], Novagen,
Invitrogen) used in commercially available vectors such
as pET and pBAD. In these two plasmid sets, genes cod-
ing for five different model proteins of varying biological
origins were placed under control of the five promoters
to cover a broad range of problems that may occur dur-
ing recombinant protein production (Table 2). Note also
that the use of one common N-terminal fusion tag for
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all proteins was avoided to study the effect of the re-
spective promoter-50-UTR regions on different 50 coding
sequences, as opposed to the study of Tegel et al. [20].
Specific gene sequence dependent parameters such as
mRNA secondary structures and the presence of rare
codons were taken into account by using optimized (for
E. coli) synthetic genes. The corresponding genes were
inserted into the two replicon types carrying the differ-
ent expression cassettes, (Table 1). Not only can expres-
sion be directly compared from different regulator/
promoter systems using these standardized vectors, but
they can also be used more generally as tools to identify
an appropriate expression system for the production of
any selected target protein.
Due to the nature of the expression systems it was ne-
cessary to use two different E. coli strains as hosts. Strain
ER2566 was chosen to compare expression from LacI/
PT7lac with XylS/Pm because it carries a chromosomal
copy of the T7 polymerase integrated into the lac op-
eron (NEB). Since the LacI/Ptrc system is also induced
by IPTG, it was decided to study expression in the same
host under the assumption that the expression of T7
polymerase does not affect expression from LacI/Ptrc
due to the specificity of this polymerase for its cognate
promoter [40]. Expression from XylS/Pm compared to
AraC/PBAD was performed in E. coli DH10B which is
unable to catabolize L-arabinose, the inducer of the
AraC/PBAD system.
Protein production levels are generally stimulated by
increased gene dosage, but none of the tested cassettes
are superior for all genes
Three different genes, encoding luciferase, an antibody
fragment fused in frame to alkaline phosphatase (scFv173-
2-5-AP) and green fluorescent protein (GFP), respectively,
were selected as models in the initial study of the perfor-
mances of the various expression cassettes (Figure 2). The
alkaline phosphatase fusion protein is translocated to the
periplasm, while luciferase and GFP are cytoplasmic. The
results were monitored as activities, meaning that only
functional proteins were measured. The only parameter
that gave a consistent response for all systems was not sur-
prisingly gene dosage, as all cassettes gave rise to more ac-
tivity when they were utilized in a high plasmid copy
number context. However, the fold increase was heavily
protein and expression cassette dependent, ranging from
1.6 for GFP (Figure 2, Panel C) to 10.4 for the alkaline
phosphatase fusion in the LacI/PT7lac system (Figure 2,
Panel B). We also observed that cell growth was strongly
affected in several of the alkaline phosphatase fusion pro-
tein producing strains, and it was generally much more dif-
ficult to obtain reproducible data for this particular
protein. We believe the reason for this is that the export of
large amounts of protein is toxic to cell growth [41], in
some cases also in the uninduced state. This potential toxic
effect may even have resulted in accumulation of mutants
that grow faster than the originally inoculated strain due to
reduced scFv173-2-5-AP production. The maximal expres-
sion level is obviously very important in the context of re-
combinant protein production, and Figure 2 shows that in
this respect none of the systems is superior for all proteins.
Generally XylS/Pm ML1-17 and LacI/PT7lac tended to pro-
duce most recombinant protein in the studies in strain
ER2566 (Figure 2, Panels A-C). The mutations in the Pm
core region were of vital importance, as XylS/Pm ML1-17
produced between 1.2- and 4.0- fold more active protein
than the corresponding wild-type system. Note also that
AraC/PBAD generated similar amounts of active protein
compared to XylS/PmML1-17 when the studies were done
in an ara negative strain (DH10B; Figure 2, Panels D-F).
LacI/PT7lac is generally known to be a very strong system
because of the efficient transcription exerted by the T7
RNA polymerase [9,40], but the comparative analysis dem-
onstrated that this system was not superior to XylS/Pm
ML1-17 for the genes studied here. Especially in the higher
copy-number plasmids, up to four times more activity was
detected in strains harboring XylS/Pm ML1-17. We also
noted in this and other related ongoing studies in our la-
boratory that to get stable expression from the LacI/PT7lac
system, ER2566 cells needed to be freshly transformed
prior to expression studies, as also recommended by
Vethanayagam and Flower [42]. Similar observations were
not made for any of the other three systems.
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Figure 1 Illustration showing how the different constructs in
the study were generated based on pSB-M1b. The upper part
shows how the alternative regulator/promoter systems were
incorporated. pSB-M1b-1-17 contains a variant of the Pm core
promoter termed ML1-17 (see text). The lower part shows the oriV/
trfA region in pSB-M1b that was replaced with the pMB1 ori
described in Table 1.
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The LacI/PT7lac system is unique by its generation of large
amounts of transcript and insoluble protein
In the analyses described above only active protein was
monitored, but potential big differences in target gene
transcript accumulation or inactive (insoluble) protein
production would not be discovered by such an analysis.
We therefore investigated to what extent total protein
production is proportional to the amounts of transcript
produced, which is not necessarily the case [43-45]. For
this purpose, we included two additional proteins, the
medically relevant human growth hormone (HGH) and
interleukin-1RA (IL-1RA), see also (Table 2). The
Table 1 Plasmids used in this studya
Name Key features Source
pTA16/pSB-M1bb m-toluate- inducible Pm, xylS activator gene, RK2 replicon, bla reporter, Kanr [31]
pET16b IPTG-inducible PT7lac, lacI repressor gene, Amp
r Novagen
pBAD/gIII_calmodulin L-arabinose- inducible PBAD, araC activator gene, Amp
r Invitrogen
pTrc99A IPTG- inducible Ptrc promoter, lacI repressor gene, Amp
r Pharmacia
pIB11-lucS pIB11 [25] with lucS under control of xylS/Pm, Kan
r unpublished
pBAD24-GFP pBAD24 with gfpmut3 insert, Ampr [32]
pHOG-173-2-5-AP pHOG plasmid with scFv173-2-5-phoA fusion gene insert, provided by Affitech AS, Oslo, Ampr unpublished
pMA-GH pMA vector (GeneArtW, Invitrogen) with GH1S insert, provided by Vectron Biosolutions AS,
Trondheim, Ampr
unpublished
pMA-T-IL-1RA pMA vector (GeneArtW, Invitrogen) with IL1RNS insert, provided by Vectron Biosolutions AS,
Trondheim, Ampr
unpublished
pSB-P0x pSB-M1b variants with combinations of different features:
P. . . regulator/promoter system M. . . xylS/Pm
M-1-17. . . xylS/Pm variant ML1-17
E. . . lacI/PT7lac (from pET)
T. . . lacIq/Ptrc (from pTrc)
B. . . araC/PBAD (pBAD)
0. . . origin of replication 1. . . RK2 replicon
2. . . pMB1 replicon
x. . . reporter gene b. . . bla
l. . . lucS
s. . . scFv173-2-5-phoA
g. . . gfpmut3
h. . . GH1S
r. . . IL1RNS This study
e.g. pSB-M2l m-toluate- inducible Pm, xylS activator gene, pMB1 ori, lucS reporter, Kan
r This study
a bla: β- lactamase gene; lucS: synthetic luciferase gene; scFv173-2-5-phoA: single-chain antibody fragment 173-2-5 alkaline phosphatase fusion gene; gfpmut3:
gene for the optimized green fluorescent protein mutant 3; GH1S: synthetic gene for human growth hormone, IL1RNS: synthetic gene for human interleukin 1
receptor antagonist.
b pTA16 was named pSB-M1g in this study for consistency purposes.
Table 2 Properties of the proteins selected as expression reporters
Protein Properties
Luciferase reporter protein, ~ 60.8 kDa, cytoplasmic localization, generally low expression, rather easy to detect, very sensitive
detection via bioluminescence assay
scFv173-2-5-AP industrially relevant protein, ~77.2 kDa, fusion protein, disulfide bonds, translocated to the periplasm, detectable
through APa fusion, AP needs to be translocated to be active [34]
GFP reporter protein, ~ 26.9 kDa, cytoplasmic localization, stable, known to be produced virtually only in its soluble form
[35], very easy to detect by direct fluorometry
HGH industrially relevant protein, ~25.1 kDa, cytoplasmic localization, usually expressed in E. coli as soluble protein [36,37]
IL-1RA industrially relevant protein, ~20.1 kDa, cytoplasmic localization, usually expressed in E. coli as soluble protein [38,39]
aAlkaline phosphatase.
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comparison was carried out in strains harbouring
plasmids with the pMB1 replicon, which as described
above generally led to a higher level of protein production
(measured as activity). One general conclusion following
from these experiments was that the LacI/PT7lac system
generated much more transcript than XylS/Pm (between
6.2 and 20 times more) and LacI/Ptrc (between 3.9 and
206 times more) for all the five tested genes. XylS/Pm
ML1-17 generated more transcript than LacI/Ptrc as well
(Figure 3), ranging from 3.3 times for lucS mRNA and 88
times for GH1S mRNA, except for the special case with
scFv173-2-5-phoA. Studies of AraC/PBAD was not included
here since it required another host (DH10B) and since
initial experiments indicated that this system (in contrast
to T7) behaved very similar to XylS/Pm in the sense that
transcript and protein amounts correlated well. At the
total protein production level the analysis revealed more
protein-specific effects compared to in the functional
studies (Figure 2). In case of luciferase the amount of
active protein was highest for XylS/Pm ML1-17 both
according to activity measurements (see above) and
deduced as soluble protein (Figure 3, Panel A). However,
the very high level of transcription in the LacI/PT7lac
system resulted in a correspondingly big production of
insoluble and inactive luciferase protein, not seen to a
comparable extent for any of the other systems.
For GFP and HGH (Panels C and D) production of sol-
uble protein was very effective in both XylS/Pm ML1-17
and LacI/PT7lac, and the final outcome at the protein level
was more similar for these proteins than for luciferase.
Generally, LacI/PT7lac had an apparent advantage by its
performance at the transcriptional level, but this potential
was often not reflected at the translational level, such that
the system often produced a vast amount of transcripts
that were either translated into inactive protein or were
not translated at all. Note also that the amounts of protein
and transcript correlated well for XylS/Pm and XylS/Pm
ML1-17 (except for scFv173-2-5-AP, Panel B), probably
mainly because the amounts of transcript were generally
much lower than for LacI/PT7lac and therefore did not
overload the translational machinery. It is also interesting
to note that, in terms of both active and total protein
produced, XylS/Pm ML1-17 and LacI/PT7lac generally
performed best. For scFv173-2-5-AP (Figure 3, Panel B) a
more complex picture was observed, but this could be
mainly related to the effects of toxic protein production
on host growth or variability among the systems in the
kinetics of induction [46].
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Figure 2 Maximum expression of three different genes placed under control of different regulator/promoter systems. Data represent
relative expression levels under induced conditions where the activity of M1x (gene x under conrol of the Pm wildtype promoter, RK2 replicon)
was set to 1.0. Expression was induced in a way that activity levels were maximized: 2 mM m-toluate for strains harboring XylS/Pm- based
constructs, 1 mM IPTG for those with LacI/PT7lac, 0.2 mM IPTG for LacI/Ptrc and 0.015% L-arabinose for AraC/PBAD. The following E. coli strains
were used as expression hosts. Panels A-C: ER2566. Panels D-F: DH10B. The naming code is the following: The capital letter represents the
regulator/promoter system and the digit represents the origin of replication; for details see Table 1. The data presented are from independent
biological replica.
Balzer et al. Microbial Cell Factories 2013, 12:26 Page 5 of 14
http://www.microbialcellfactories.com/content/12/1/26
Uninduced expression levels are highest for LacI/Ptrc and
lowest for AraC/PBAD
The tightness of the different regulator/promoter sys-
tems is another important feature, particularly for pro-
duction of host-toxic proteins [47]. We studied this with
the same set-up as for induced conditions, using lucifer-
ase, scFv173-2-5-AP and GFP, and as expected the back-
ground increased for all systems when the higher copy
number vectors were used. The increase was in most
cases approximately proportional to that of the plasmid
copy number. Therefore, only findings collected from
strains harboring pMB1-based plasmids are presented
(Figure 4).
Generally, LacI/Ptrc tended to be the leakiest system
producing 3.8 to 8.2 times more active protein than XylS/
Pm under uninduced conditions. Similarly, XylS/Pm
ML1-17 displayed 2.8- to 5.8-fold higher background ex-
pression than the wild-type system. AraC/PBAD appeared
to be, as expected, the tightest system giving rise to 0.1
and 0.4 times the background level for luciferase and
scFv173-2-5-AP, respectively. LacI/PT7lac was also quite
tightly regulated although it generated the highest back-
ground expression for GFP (Figure 4, Panel C).
The ratio between the induced and the uninduced ex-
pression levels was protein dependent with relatively small
induction windows for svFv173-2-5-AP (1.2-25) and large
for luciferase (60–3,000). In strain ER2566, XylS/Pm and
LacI/PT7lac displayed the highest induction windows, while
LacI/Ptrc was by far the least inducible system (0.1-0.2
times compared to XylS/Pm). In DH10B, induction ratios
for AraC/PBAD were 1.3-27 times higher than the ratios of
XylS/Pm and XylS/Pm ML1-17. These results are consist-
ent with a previous report documenting that the induction
ratio in the AraC/PBAD system can reach up to 1,200-fold
when functionally compared for the phoA reporter gene
[11]. As for XylS/Pm [24,25], the induction level can also
be modulated over a wide concentration range by varying
the inducer concentration. In addition, uninduced levels
can be even further reduced by the presence of glucose,
which represses the expression in this system [47]. The
main disadvantage of the AraC/PBAD system is that the
inducer can be metabolized in most strains of E. coli.
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The predicted translational efficiencies of the ribosomal
binding sites vary over a wide range
The DNA region corresponding to the 50-UTR plays a
central role in regulation of gene expression [48-50]. It
covers the untranslated nucleotides at the 50 end of the
mRNA [51,52], including the ribosome binding site
(RBS) that together with the translational start site influ-
ence expression [28,49,53]. One program frequently used
to analyse the expected efficiency of these nucleotide se-
quences is the RBS calculator [54]. We applied its re-
verse engineering function on the various 50-UTR-gene
combinations used in the study and determined the
translation initiation rate (TIR) values of the respective
expression systems. The most striking finding was that
the relative differences between the calculated TIRs of
the four cognate RBSs were rather similar for all the five
genes studied (Figure 5), although there were exceptions
(see LacI/PT7lac for HGH and AraC/PBAD for IL-1RA).
Generally, the calculator predicted that the TIR values of
the LacI/PT7lac and the AraC/PBAD RBSs were higher
than those of XylS/Pm and LacI/Ptrc RBSs, suggesting a
more efficient translation. The relative differences be-
tween the TIRs of the LacI/Ptrc and XylS/Pm RBSs
depended on the coding sequence.
To correlate the calculated TIR values with our experi-
mental data is not straight forward because the total
protein levels are obviously also dependent on the effi-
ciencies of the promoter sequences, which are not a part
of the calculation of the TIR values. However, by com-
paring both transcript and protein amounts available
from the data presented in Figure 3 such effects can at
least partly be taken into account. The amounts of accu-
mulated transcripts derived from LacI/PT7lac were gener-
ally highest and combined with a predicted more
efficient TIR one might expect that this system would
come out best at the protein level in all cases. However,
this prediction was only in agreement with the luciferase
data, and with the ScFv-173-2-5-AP and IL-1RA data to
a more limited extent. In contrast, for GFP and HGH
the experimental data did not support the prediction. It
should also be remembered that efficient translation in
itself may contribute to more accumulated transcript
due to translation-mediated transcript stabilization
[55,56]. For XylS/Pm ML1-17 there appeared to be more
protein per transcript compared to LacI/PT7lac and the
total amounts of protein were at least equally good for
this system, presumably indicating a better balance be-
tween the capacities of the transcriptional and transla-
tional systems. For LacI/Ptrc the calculator correctly
predicted a very poor expression of HGH.
In general, it is possible to some extent to use the RBS
calculator to predict which regulator/promoter system
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would produce most protein. However, RBS function is
just one among several parameters that affect the final
protein production level. We have analyzed the previ-
ously reported very efficient UTR variants obtained by
screening [28]. Despite the great stimulatory effect of
these screened UTRs on protein expression (up to 20-
fold), the calculator only predicted minor improvements
relative to the wild-type sequence (between 1.5 and 3.6
times for the best variants).
Flow cytometry analysis of GFP expression in individual
cells revealed significant differences among the various
regulator/promoter systems
Analyses of recombinant protein expression are mostly
carried out at the level of cell populations, potentially
masking significant differences in the level of expressed
proteins between individual cells, which are known to
occur [57,58]. If such heterogeneity exists it may repre-
sent another possibility for system improvement, e.g. by
finding ways to reduce the fraction of cells with low ex-
pression level. This is also relevant in metabolic engin-
eering projects involving metabolite flux control in
biochemical pathways [59].
To analyze the level of homogeneity we used flow cy-
tometry to quantitate GFP as it can be easily detected
and because it was shown to be produced at high levels
from the regulator/promoter systems used in this work,
thus representing a relevant example in recombinant
protein production. The fluorescence level, which re-
flects the number of GFP molecules, among the majority
of cells harvested at a given time point typically varied
in a 5–10 fold range (Figure 6). In most cases, the fluor-
escence values fell within a signal peak, which moved to
higher intensities with extended time after induction, as
expected. The highest production levels were found in
cells expressing GFP from XylS/Pm ML1-17, LacI/PT7lac
and AraC/PBAD (where a different host strain was used),
also consistent with what was observed at the population
level. However, the analysis also revealed several new ob-
servations. For the two XylS/Pm-based systems the dis-
tributions were broader for the wild-type system
(Figure 6, Panel A) than for XylS/Pm ML1-17 (Figure 6,
Panel B), meaning that the promoter mutations im-
proved culture homogeneity. The reasons for this are
not clear but they might be related to differences in the
efficiency of transcription initiation. Fluorescence distri-
butions of cells expressing GFP from LacI/PT7lac
(Figure 6, Panel C) were quite unique compared to those
from the other systems. The expression profile at the
time of induction is surprisingly broad in this system
compared to the profiles of the remaining systems, pos-
sibly indicating low and varying (between individual
cells) levels of T7 RNA polymerase production. Sec-
ondly, from two hours post induction onwards, two
peaks became visible, one at rather low and one at rather
high fluorescence values. The peak heights were also
strongly reduced at the end. Most probably, the peak
around lower fluorescence values late after induction re-
flects the formation of two subpopulations of cells as de-
scribed by Zhao et al. [60], one being soluble GFP
bearing and the other being dominated by inclusion
bodies. Our findings also support those of a previous
IL-1RA
0
10
20
30
40
HGH
0
10
20
30
40
GFP
0
10
20
30
40
B
TIR           2,746        23,459         710         48,810TIR 9,486       33,626        3,354       120,064
D
TIR 820           9,537          40         11,408
E
TIR 572         6,897         2,393       20,756
C
TIR 3,309 22,427       6,588      55,866
Luciferase
0
10
20
30
40
R
el
at
iv
e 
TI
R
 M
 =
 1
.0
R
el
at
iv
e 
TI
R
 M
 =
 1
.0
R
el
at
iv
e 
TI
R
 M
 =
 1
.0
M E T B
M E T BM E T B
M E T B
R
el
at
iv
e 
TI
R
 M
 =
 1
.0
A ScFv173-2-5-AP
0
10
20
30
40
R
el
at
iv
e 
TI
R
 M
 =
 1
.0
M E T B
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report where GFP expression was studied from a pET
vector context [4].
The LacI/Ptrc system (Figure 6, Panel D) is character-
ized by a very even signal distribution throughout the
entire induction period. Interestingly, the mean fluores-
cence remained constant already two hours after induc-
tion, possibly a consequence of a very fast activation of
transcription after inducer addition in this system.
The AraC/PBAD system, displayed a similar behaviour
as XylS/Pm meaning that it takes an extended time until
all cells are induced as reflected by a tail of the distribu-
tion towards low fluorescence values (Figure 6, Panel E).
One hour after induction, the distribution fell into a sin-
gle, rather narrow peak that was shifted towards higher
fluorescence values over time.
The outcomes of the flow cytometry experiments
showed that there is a quite big variation in GFP expres-
sion level among individual cells. By better understanding
the factors controlling this variability it may become pos-
sible to improve expression at the population level. This
conclusion is supported by the observation mutations in
the Pm promoter region lead to more homogeneity.
Conclusions
Development of efficient recombinant gene expression pro-
tocols is often based a lot on case-specific trial and error
approaches, and the results reported here contribute to the
understanding of why. We have summarized the various
observations (Table 3), and the LacI/PT7lac system can be
distinguished from all the other systems by its general tends
to give rise to more transcript than all the other systems.
The difference relative to the XylS/Pm system may be
reduced or eliminated by incorporating more mutated
control elements, but at the moment this would lead to
very high levels of protein synthesis also in the absence of
inducer [31]. Since we have shown before that even the
wild-type XylS/Pm system can in some cases generate pro-
tein production at industrial levels it is clear that LacI/PT7lac
will only have an important advantage in those cases where
the amount of transcript is the bottleneck. The experiments
with GFP, HGH and IL-1RA illustrate cases where this has
limited or no relevance (compared to XylS/Pm ML1-17). In
contrast, for luciferase the amounts of transcript appears to
be very important, but the potential in the LacI/PT7lac
system is in this case lost by the excessive production of
inactive protein. LacI/Ptrc generally has the advantage (for
applications where this might be relevant) of a fast onset of
protein production and a homogenous expression profile.
However, both high levels of expression in the absence of
inducer and comparatively low total production make it the
least desirable if one is aiming at highest possible level of
expression. AraC/PBAD seems to be best with respect to
tight regulation of the uninduced state coupled with high
expression when induced. The XylS/Pm system has a big
5
4
3
2
1
0
R
el
. f
re
qu
en
cy
[x1
0-2
]
20 min
40 min
60 min
120 min
180 min
300 min
0 min
0.1 1 10 100 1000
B
5
4
3
2
1
0
M-1-17
Fluorescence [au]
R
el
. f
re
qu
en
cy
[x1
0-2
]
Fluorescence [au]
0.1 1 10 100 1000
A
5
4
3
2
1
0
M
R
el
. f
re
qu
en
cy
[x1
0-2
]
Fluorescence [au]
0.1 1 10 100 1000 0.1 1 10 100 1000
DC
5
4
3
2
TE
5
4
3
2
1
0
R
el
. f
re
qu
en
cy
[x1
0-2
]
Fluorescence [au]
R
el
. f
re
qu
en
cy
[x1
0-2
]
1
0
Time [min] 0       20      180     300
Mean 0.32   2.68    49.5    56.1
Spread [CV] 65.6   92.2     63.4   69.9
Time [min] 0       20      180     300
Mean 6.51   17.6    135     153
Spread [CV]   83.5   48.0    47.0    48.2
Time [min] 0       20      180     300
Mean 10.9    19.6    216     254 
Spread [CV]  150     72.7    60.9    96.0
Time [min] 0       20      180     300
Mean 1.55   11.9    33.7    33.5
Spread [CV]   46.7   47.0    44.0    42.0
0.1 1 10 100 1000
BE
Fluorescence [au]
Time [min] 0       20      180     300
Mean 0.13   1.01    112     128
Spread [CV]   54.5   175     47.1    59.5
Time after
induction
Figure 6 Analysis of the distribution of expression using flow cytometry. Strains were grown under standard conditions. At the time point
of induction (t= 0 min) and at several points afterwards (t= 20–300 min), samples were collected, snap-frozen, and collectively analyzed with a
flow cytometer. The spread is represented by the coefficient of variation (CV). Panels A-D: ER2566, Panel E: DH10B.
Balzer et al. Microbial Cell Factories 2013, 12:26 Page 9 of 14
http://www.microbialcellfactories.com/content/12/1/26
advantage of not being strain dependent in E. coli, and it is
probably easiest to adapt to new bacterial hosts for cases
where E. coli cannot be developed to perform in a satisfac-
tory way. In summary we believe that the vectors developed
for this study can be used as an efficient early test system
for new proteins, perhaps by using XylS/Pm ML1-17, LacI/
PT7lac and AraC/PBAD. The outcome of such a simple first
experiment will probably often lead to an identification of
the nature of the main bottleneck for this particular case,
shortening the time from testing to development of a good
production process. The further studies would involve a
detailed analysis of parameters such as growth media
composition, culture incubation temperature and host
strain, which are known to affect recombinant protein
expression at various levels.
Methods
Strains, standard DNA manipulations and growth
conditions
E. coli DH5α (Bethesda Research Laboratories) was used
for plasmid propagation during cloning steps. Recom-
binant DH5α strains were grown at 37°C in liquid Luria
Bertani (LB) broth or on solid LB plates with appropriate
antibiotics (kanamycin 50 μg/mL; ampicillin 200 μg/
mL). E. coli ER2566 (New England Biolabs, NEB) and E.
coli DH10B (Invitrogen) served as expression hosts dur-
ing the comparative studies. In comparison to the com-
monly used strain E. coli BL21(DE3), the former strain
offers higher transformation efficiency for toxic clones
and less background expression (NEB). All DNA manip-
ulations were carried out according to standard proce-
dures [61] or according to manufacturers’ instructions.
PCR was performed using the Expand High Fidelity PCR
systems kit (Roche), and essential regions in PCR prod-
ucts were verified by sequencing. Functionality of the
regulator/promoter systems was confirmed using bla as
reporter gene determining the levels of resistance to
ampicillin as described previously [62].
Vector constructions
PCR primers used during various cloning steps are listed
in Table 4. Plasmids used as templates or constructs that
were generated in this study are listed in Table 1.
Construction of pSB-M2b: The region of pBAD_gIII_
calmodulin containing the origin of replication from
pMB1 was PCR amplified using primer pair Pwitw6_badF
Table 3 Summary of the findings derived from the comparative expression study
Category Regulator/promoter system References
XylS/Pm and Pm ML1-17 LacI/PT7lac LacI/Ptrc AraC/PBAD
Components XylS regulator LacI regulator LacI regulator AraC regulator
Pm promoter (native or
variant)
T7lac promoter trp/lac hybrid promoter PBAD promoter
CAP binding site CAP binding site
Strain requirements none strain supplying T7
polymerase
none araBADC-/ araEFGH+
strain
(and lysozyme)a
Medium requirements none (glucose)b none (glucose)b [3,10,11,42]
Range of inducer 0.001 - 2.0 mM 0.05 - 2.0 mM 0.05 - 2.0 mM 0.001% - 1% [1,25]
Expression level low - high intermediate - high low - intermediate intermediate - high This study
Basal expression low - high low - high High low This study
Induction ratio intermediate intermediate-high Low high This study
Accumulated transcript low - intermediate high below detection -
intermediate
intermediate This study
RBS strength weak - intermediate intermediate - strong weak - intermediate strong This study
Homogeneity homogeneous
populations
mixed populations homogeneous
populations
mixed populations This study
Recommended
applications
high level expression high level expression (high level expression)c high level expression
expression of toxic
proteins
(expression of toxic
proteins)c
(metabolic engineering)c expression of toxic
proteins
metabolic engineering (metabolic
engineering)c
This study
a Expression of lysozyme, the natural inhibitor of T7 RNA polymerase, reduces the basal transcription from PT7lac.
b Supplementing glucose leads to catabolite repression which reduces basal transcription levels.
c Limited suitability. See ‘Results and discussion’ section for detailed information.
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and Pwitw6_badR. In parallel, pair Pwitw4_AscI and
Pwitw5_SpeI was used to amplify pSB-M1b [31] excluding
the RK2 ori (trfA coding region and the oriV origin of
replication). After digestion with AscI and SpeI of both
the amplified pMB1 ori and the pSB-M1b -resulting PCR
product, the two fragments were ligated to each other
resulting in plasmid pSB-M2b. The difference between
copy-numbers of RK2- and pMB1-based plasmids was
confirmed by agarose gel electrophoresis. Construction of
pSB-P0b introducing different regulator/promoter sys-
tems: Three different regulator/promoter systems were
chosen to substitute the region spanning xylS/Pm in pSB-
M1b and pSB-M2b. The lacI/PT7lac region was amplified
from pET16b using ET_AgeI_fwd and ET_NdeI_rev and
inserted into the two depicted backbones using NdeI and
AgeI, generating pSB-E1b and pSB-E2b. The lacIq/Ptrc
region was amplified from pTrc99A using TRC_AgeI_
fwd1and TRC_NdeI_rev1 prior to insertion into pSB-M1b
and pSB-M2b using AgeI and NdeI, generating pSB-T1b
and pSB-T2b. Finally, the PCR product covering the
araC/PBAD region from pBAD/gIII_calmodulin generated
with the primers BAD_BbsI_fwd and BAD_NdeI_rev was
inserted into the above mentioned backbones using BbsI
and NdeI, creating pSB-B1b and pSB-B2b. In order to in-
sert the Pm variant ML1-17 [27], pSB-M1b and pSB-M2b
were digested with XbaI and PciI removing the Pm core
promoter region which was replaced by two annealed
oligonucleotides that constitute the double-stranded Pm
ML1-17 fragment with XbaI and PciI compatible ends,
creating pSB-M1b-1-17 and pSB-M2b-1-17. Introduction
of other genes of interest: All pSB-P0b variants, except for
pSB-B2b, were digested with NdeI and BamHI to excise
the bla gene and to insert the lucS gene from pIB11-lucS
instead, generating pSB-P0l variants. pSB-B2b and pSB-
M1l were digested with NdeI and KpnI. The resulting
DNA fragment corresponding to the pSB-B2 backbone
and the lucS gene were ligated to each other to generate
pSB-B2l. The scFv173-2-5-phoA gene was PCR cloned
from pHOG-173-2-5-AP with primer pair pelB_fwd and
APhis_rev2. The enzyme combination NdeI and BamHI
was used to replace the bla gene from pSB-M1b with
the digested scFv173-2-5-phoA PCR product resulting in
pSB-M1s. From there on NdeI and BamHI were used to
generate all pSB-P0s variants, except for pSB-B2s. This
construct was generated by digesting pSB-B2b and pSB-
B1s with BamHI and ligating the pSB-B2 backbone with
the scFv173-2-5-phoA BamHI digested insert from pSB-
B1s. gfpmut3 originating from pBAD24-GFP was inserted
into the pSB-P0b variants using NdeI and BamHI with the
exception of pSB-B2b. Instead, BamHI was used to excise
the gene from pSB-B1g and to place it into pSB-B2 back-
bone (originating from pSB-B2l) to generate pSB-B2g.
Genes GH1S and IL1RNS were excised from pMA-GH
and pMA-T-IL-1RA with NdeI and BamHI and trans-
ferred to the pSB-P0b variants with the Pm, Pm ML1-17,
PT7lac and Ptrc promoter using the same enzymes,
resulting in pSB-P0h and pSB-P0r variants.
Growth conditions for comparative expression studies
The general cultivation protocol was based on recom-
mendations published by the European Molecular Biol-
ogy Laboratory (EMBL) [63]. For E. coli cultivations LB
medium was chosen because it is widely used among
molecular biologists and at the same time it was avoided
to use media with glucose as a carbon source due to the
influence of glucose on background expression from PT7lac
and PBAD through catabolite repression [64]. A growth
temperature of 30°C was applied for slowing down the
growth rate of E. coli, as this generally leads to more sol-
uble protein [65]. Initially the kinetics of protein accumu-
lation was studied for all expression cassettes, using GFP
(fluorescence) and luciferase (activity) as the main models.
Table 4 Oligonucleotides used in this study
Name Sequence (50→ 30)
a) PCR primers
Pwitw4_AscI AAAGTGAGGGCGCGCCGGTTGATGAGAG
Pwitw5_SpeI ATCCACCGGAACTAGTCCCCTGCTC
Pwitw6_badF AGACTAGTAAGCCCTCCCGTATCGTAGTTA
Pwitw6_badR TGGCGCGCCAGATGCGTAAGGAGAAAA
TACCG
ET_AgeI_fwd GATGGCCCATATGATATCTCCTTCT
ET_NdeI_rev GATCACCGGTCCAGTGATCGAA
BAD_BbsI_fwd GGCCTTTCGTCTTCCCGGCATCCGCTTA
CAGACA
BAD_NdeI_rev GACGCCCATATGTAATTCCTCCTGTT
AGCCCAAAAAACG
TRC_AgeI_fwd1 TGCATGTGTCACCGGTTTTCACCGTC
TRC_NdeI_rev1 GAGCTCGAATCATATGGTCTGTTTCCTG
pelB_fwd AGCTACATATGAAATACCTATTGCCTACG
APhis_rev2 AGGATCCGAGCCTTTCGTTTTATTGATGC
b) qRT-PCR primers
RT-synluc_fwd2 CCATGGCTTCGGCATGTT
RT-synluc_rev2 ACACGAAAGCCGCAAATCA
gfpmut3_fwd1 CATGGCCAACACTTGTCACT
gfpmut3_rev1 CTGCTTCATGTGATCTGGGTATCT
RT-hGH.fwd1 GCCTGTGTTTTAGCGAAAGCAT
RT-hGH.rev1 AGATTGCTTTTCTGCTGGGTTT
RT-IL-1-RA.fwd1 ATTGATGTGGTGCCGATTGA
RT-IL-1-RA.rev1 TCAGACACATTTTACCACCATGAA
scFv198.fwd GAAGGGCCGGTTCACCAT
scFv255.rev CATTTGCAGATACAGCGTGTTCT
RT-16S-Fwd ATTGACGTTACCCGCAGAAGAA
RT-16S-Rev GCTTGCACCCTCCGTATTACC
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The inducer concentrations and culture harvesting times
post induction were varied and we found that five hours
induction was sufficient to reach a plateau of accumulated
protein per OD unit of cells. For GFP the accumulation
rate was nearly constant (slightly lower from 3–5 hours)
over this time-period. For most of the proteins it was
complicated to follow the kinetics accurately since there
was no quantitative method for measurement available,
and in case of luciferase activity measurements may not
necessarily correlate exactly with the accumulation kinet-
ics of the insoluble fraction.
Recombinant E. coli ER2566 and DH10B strains were
grown in 2 ml LB supplemented with 50 μg/ml kanamycin
at 30°C over-night. Then 15 ml of LB with kanamycin in
shake flasks were inoculated with the overnight culture to
an initial OD600 of 0.05. Following incubation at 200 rpm
and 30°C expression was induced at OD600= 0.5-0.6 as fol-
lows: 2 mM m-toluate for strains harboring Pm- based
constructs, 1 mM IPTG for those with PT7lac, 0.2 mM
IPTG for Ptrc and 0.015% L-arabinose for PBAD. Growth
was continued for 5 more hours at 30°C.
Transcript analysis by qRT-PCR
At harvest, 0.5 ml of culture was stabilized with RNA pro-
tect (Qiagen) prior to freezing. The subsequent total RNA
isolation, cDNA synthesis and relative transcript quantifi-
cation by qRT-PCR was performed as described previously
[28]. Primer pairs used during amplification are listed in
Table 4. Transcript generated from the 16S rRNA gene
was used for normalization.
Activity measurements of the different reporters
The luciferase assay was performed using the Luciferase
assay System (Promega). At harvest, the cell culture was
normalized to an OD600 of 0.5. 90 μL of this mixture was
supplemented with 10 μL of K2HPO4, pH 7.8, 20 mM
EDTA prior to lysis with the Luciferase Cell Culture Lysis
Reagent (CCLR, Promega). The remaining steps of the
protocol were carried out according to the manufac-
turer’s instructions except that the luciferase activities
were determined from 10 μL lysed culture mixed with
50 μL of substrate. The alkaline phosphatase assay
was performed as described previously [66]. Fluore-
scence measurements of strains expressing GFP were
performed with the FLUOstar Omega instrument
(BMG Labtech) together with the corresponding
Omega Software. Fluorescence intensity was deter-
mined directly from the cultures using an appropriate
filter set (excitation: 485 nm; emission: 520 nm).
Values were normalized against the optical density.
Data were acquired from three biological and thereof
three technical replica.
Protein analysis by SDS-PAGE
For SDS-PAGE analysis 50 ml culture volume was used.
Because of impaired growth of recombinant strains ex-
pressing scFv173-2-5-AP, 3xLB was used to get sufficient
cell mass for analysis. The general growth conditions
were as described above for the comparative expression
studies. At harvest, bacterial pellets were washed with
0.9% NaCl and 100 mg pellet (wet weight) was frozen
until further processing. Pellets were resuspended in
lysis buffer (50 mM Tris–HCl, pH 8.0, 1 mM EDTA,
100 mM NaCl, 8 mM MgCl2). The solution was soni-
cated using a Branson Sonifier DSM tip (sonication for
3.5 minutes on ice, duty cycle 35% and output control
3.0). Soluble and insoluble fractions were separated by
centrifugation and treated with 62.5 U/ml Benzonase nu-
clease (Merck). Protein gels were run under denaturing
conditions using ClearPAGE 10% gels and ClearPAGE
SDS-R Run buffer (C.B.S. Scientific) followed by staining
with Coomassie Brilliant blue R-250 (Merck).
Flow-cytometry
Cultures were grown essentially as decribed for SDS-
PAGE analysis. At various time points after induction, 1
ml of culture was collected, supplemented with glycerol to
10% and snap-frozen in liquid nitrogen until further ana-
lysis. For single-cell fluorescence measurements, samples
were thawed on ice and diluted in PBS. Flow cytometry
was performed using the CyFlowW Space flow cytometer
(Partec) equipped with a 488 nm blue solid state laser
(200 mW) and a 536/ 40 nm band pass filter. For each
sample, 150,000 events were collected at a rate between
800 and 2,000 events per second. Data were analysed
with the Windows™ XP FloMax(R) software (Quantum
Analysis). The mean and spread (coefficient of variation
(CV)) of the distributions were calculated over all collected
values after gating.
Abbreviations
50-UTR: 50-untranslated region; qRT-PCR: Relative quantification real-time RT-
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